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INFR  interferonγ receptor 
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JAK   just another kinase, janus kinase  
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KSR  kinase suppressor of Ras 
Map kinase mitogen activated protein kinase 
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Mig6  mitogen inducible gene 6 
MKP  Map kinase phosphatase 
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MSP  macrophage-stimulating protein  
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NGF  nerve growth factor 
P90RSK 90kDa ribosomal S6 kinase 
PAK  p21-activated protein kinase 
PDGF  platelet-derived growth factor 
PIs  inositol phospholipids 
PI3 kinase phosphatidylinositide-3’-kinase 
PKA  protein kinase A  
PKC  protein kinase C 
PLCγ  Phospholipase Cγ 
PP1  protein tyrosine phosphatase 1 
PP2A  phospho-protein phosphatase 2A 
PTP  protein tyrosine phosphatase 
PTEN  phosphatase and tensin homologue deleted on chromosome 10 
PTP1B protein tyrosine phsphatase 1B 
PYK2  proline-rich tyrosine kinase 2 
Ralt  receptor-associated late transducer 
RTK  receptor tyrosine kinase 
SCF  stem cell factor 
SH2,3  Src-homology domain 2,3 
SHC  SH2-containing collagen-related protein  
SHP1-2 SH2-containing phosphatase 1-2 
SLAP  Src-like-adapter-protein 
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Ssr2   signal sequence receptor beta 
STAT3 signal transducer and activator of transcription 3 
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Summary 
 
Hepatocyte Growth Factor (HGF) is a pleiotropic factor acting on cells expressing the 
Met receptor tyrosine kinase. HGF/Met signaling has been described in detail and it is 
known to control cell migration, growth and differentiation in several embryonic organs 
and to be implicated in human cancer. Conversely, little is known about the 
transcriptional targets that lead to Met-mediated biological functions. Also, little is 
known about the physiological mechanisms that attenuate Met signaling. 
This work provides the results of a screen for genes transcriptionally regulated by Met in 
several cell lines and addresses the functions of the highly inducible gene Mig6 
(Mitogen-inducible-gene6, also called Gene 33 and RALT). By the use of Met loss of 
function mutant mice Met is shown to be the major inducer of mig6 in hepatocytes and 
lungs of E13.5 embryos. Mig6 is shown in turn to negatively regulate HGF/Met-induced 
cell migration. The effect is observed by Mig6 overexpression and reversed by Mig6 
siRNA knock down experiments indicating that endogenous Mig6 is part of a mechanism 
that inhibits Met signaling. Mig6 functions in cells of hepatic origin and in neurons 
suggesting a role for Mig6 in different cell lineages. Mechanistically, Mig6 requires an 
intact Cdc42/Rho interactive binding (CRIB) domain to exert its inhibitory action 
suggesting that Mig6 acts at least in part distally from Met possibly by sequestering Rho-
like GTPases. Because Mig6 is also induced by HGF stimulation, this work provides 
evidence that Mig6 is part of a negative feedback loop that attenuates Met functions in 
different contexts and cell types. 
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Introduction  
 
Cell communication and surface receptor proteins 
 
Multicellularity was a relatively late evolutionary innovation presumably because 
of the difficulties of developing the necessary intercellular communication mechanisms 
(Bruce Alberts, 2002). Cells must communicate in a complex way in order to control 
their behaviors for the benefit of the organism as a whole. Communication depends, in 
many cases, on extracellular signaling molecules which are produced by cells to signal to 
their neighbors or to other cells further away. It also depends upon systems of proteins 
within each cell that enable the signaling in a cell-specific manner. These proteins include 
cell surface receptor proteins and a variety of intracellular signaling proteins which 
propagate the signal inside of the cell’s appropriate compartments. Depending on the 
organism, signaling molecules may include peptides, amino-acids, nucleotides, steroids, 
fatty acid derivates, or dissolved gas such as nitric oxide. Most of these signaling 
molecules are released into the extracellular space by exocytosis. Others freely diffuse 
from the cellular membrane to the extracellular space.  
Regardless of the nature of the signaling molecules, the target cells respond 
through a specific receptor, which binds the signaling molecules and initiates a signaling 
cascade inside the cell, resulting in a specific alteration of the behavior of the target cell. 
In many cases the receptors are transmembrane proteins that upon binding of their 
specific ligands become activated and generate the signaling cascade responsible for a 
specific biological function. 
Cell surface receptors can be divided into three main groups, each of which 
transduces the signal in different ways. Ion-channel linked receptors can transduce the 
signal by opening or closing the channel upon ligand binding, allowing passage of ions. 
The G-protein coupled receptor indirectly activates or inactivates membrane-bound 
enzymes or ion-channels via GTP-binding proteins (G-proteins). Enzyme linked surface 
receptors either act directly as enzymes or are coupled to an enzyme. Generally these 
Introduction 
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enzymes are protein kinases which phosphorylate specific target molecules that initiate 
the signal transduction cascade that drives the cell to a specific cellular response.     
 
Receptor tyrosine kinases and signal transduction  
 
The most abundant members of the enzyme-linked surface receptors with an 
intrinsic enzymatic activity are the Receptor Tyrosine Kinases (RTK). These receptors 
share a general characteristic structure: they are integral membrane proteins, spanning the 
cellular membrane once, with the N-terminal of the protein on the extra cellular side of 
the membrane, and the C-terminal part on the cytoplasmic side. The cytoplasmic part of 
these receptors also shares the enzymatic activity: they are tyrosine kinases. Many 
tyrosine kinases were first identified in the early 1980’s as cellular counterparts of viral 
oncogenes, whose isolation was made possible by the transforming activity of their 
constitutively active products (Snyder and Bishop, 1984). During the following ten years 
together with the cloning and characterization of several RTKs, it was established that the 
pre-requisite for RTK activation and the consequent initiation of the signal transduction 
pathways was ligand-induced stabilization of receptor-dimers (Ullrich and Schlessinger, 
1990). Dimer formation results in a conformational change of the tyrosine kinase domain, 
leading to a substantial increase of substrate (the receptor itself) concentration and to its 
phosphorylation (a process referred to as auto-phosphorylation) (Mohammadi et al., 
1996a; Mohammadi et al., 1996b). The auto-phosphorylation event results in the 
initiation of the signaling cascade. 
On the other hand as early as the 1990’s it became clear that the receptors mediate 
the activation of the signal transduction via the phosphorylation of specific tyrosine 
residues outside of the kinase domain. Together with the discovery of the SH2 domain as 
a phospho-tyrosine binding modules it became clear that specific phospho-tyrosine 
residues act as high affinity-docking sites for SH2-containing cytoplasmic molecules 
relocating them to the plasma membrane (Koch et al., 1991). This recruitment, often 
followed by activation via tyrosine phosphorylation, brings the effectors in the optimal 
position in order to generate secondary messengers and to start the signal transduction 
cascade from membrane-anchored proteins. Many signaling molecules also contain other 
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protein-modules that allow them to interact specifically with other proteins as part of the 
signaling process. These modules include the SH3 domain which binds to proline-rich 
motifs allowing protein-protein interactions between intracellular proteins. The presence 
of SH2 together with SH3 domains in many signaling molecules is one of the 
mechanisms by which additional signaling partners can be indirectly recruited to the 
receptor, thus assembling multi-molecular complexes capable to initiate intricate 
signaling pathways. Since the identification of the SH2 domain, shortly followed by the 
SH3-domain discovery, searches for other conserved domains have yelded many 
additional contributors to the complex mechanisms of signal transduction. These 
networks of protein-protein interactions allow for rapid, spatially controlled and 
reversible activation of signaling pathways downstream of RTKs. 
 
RTKs and their paradigm: do all the pathways lead to the same outcome?  
  
As mentioned above many signal transduction mechanisms transmit information 
from the extra cellular space, or an intracellular compartment, to the nucleus, where they 
influence gene expression and thus biological response. There is a spectrum of RTK-
activated intracellular signaling pathways, some driven by adaptor proteins and some 
driven by enzymes. Different RTKs mediate a broad spectrum of biological functions 
ranging from proliferation, cell motility, and differentiation, to protection from apoptosis. 
However, different RTKs despite their distinct biological effect nevetheless stimulate 
similar arrays of downstream pathways (Fig.1). Several studies in vitro, in flies and 
vertebrates have addressed the question of how different RTKs, even sharing similar 
activated signaling pathways, can drive a receptor-specific outcome (Tan and Kim, 1999) 
(Simon, 2000). In vitro studies of the tyrosine kinase receptor for Platelet-Derived 
Growth Factor (PDGF receptor) suggested that the pathways downstream of the receptor 
are in fact redundant in terms of what gene they can activate (Fambrough et al., 1999). In 
other words, individual effectors activated by the receptor are extensively cross-talking, 
resulting in the transcriptional activation of broadly overlapping sets of genes. 
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Figure 1. RTKs use similar signal 
transduction cascades. 
RTKs stimulate similar arrays of 
downstream signaling pathways via 
the recruitment of either adaptor 
proteins, such as Grb2, Shc and 
GAB1, or molecules with enzymatic 
activity such as PLCγ, Src and PI3 
kinase. The activation of RTK-
mediated signaling leads to 
translational and transcriptional 
regulation and/or cytoskeletal 
protein modification resulting in the 
control of a broad spectrum of 
biological functions.(modified from 
(Technology, 2002) 
 
 
However, experiments performed in the whole animal, expressing signaling mutant forms 
of the RTK Met, suggested that the activation of specific, non redundant, effectors is 
required for receptor-mediated biological functions (Maina et al., 2001). These studies 
concluded that each individual receptor superimposes, above a generic threshold 
signaling level, different qualitative signals to achieve specific biological functions. The 
results from the in-vitro and in-vivo data are difficult to compare, due to the use of two 
different RTKs and systems. In the case of PDGF studies, Fambrough and co-workers 
assayed, in ligand saturating conditions, immediate-early gene expression by 
transcriptional profile. In contrast the studies on Met receptor used a classical in-vivo 
phenotypical analysis. Nonetheless the experiments performed on the whole organism 
suggest that signaling pathways are not completely redundant at the phenotypic level 
(Maina et al., 2001). 
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The two faces of RTKs: involvement in physiological and pathological processes 
 
Another extensively studied aspect of RTK signaling is how, during development, 
a signal that in one context causes a cell to proliferate, in another can cause 
differentiation and in a third apoptosis. Obviously, for a cell’s fate, not only the 
qualitative difference between various activated pathways is important, but it is also 
important for a cell to have precise developmental characteristics in order to properly 
respond to a signal. In general during development, the outcome of the signaling event is 
not only determined by the signal itself but also by the developmental state of the cell 
receiving it. This developmental state consists of the various cellular targets (such as 
transcription factors, cytoskeletal proteins, etc.) that are primed to respond to the signal. 
Whether they are primed depends on the cellular developmental history. Despite these 
differences in cellular competence during the development of an organism, signaling 
events nevertheless have to be precisely regulated in space, time and strength. A signal 
that is produced at the wrong time and place can lead to serious developmental defects. 
Signals must furthermore be robust enough to ensure that the cell receives them at a high 
enough level in order to respond. Finally, the signals must operate in cells and tissues of 
different origins and with different kinetic properties. Spatial and temporal precision, 
robustness and versatility of a signal represent stringent requirements for intracellular 
signals.  
There is striking evidence from animal models that deregulated RTKs can drive 
pathological phenotypes. Experimentally, there are two classical approaches used in order 
to investigate whether receptor-mediated signaling is required or sufficient for a 
particular biological function: the first is the inactivation of the receptor/signaling (loss of 
function) and the second is its over-activation (gain of function). The loss of function 
approach has shown that RTKs are necessary to mediate a broad range of cellular 
responses ranging from proliferation, differentiation, and migration to protection from 
apoptosis. Conversely, gain of function experiments indicate that all the naturally 
occurring receptor-mediated events during development and adulthood, when de-
regulated by uncontrolled receptor-mediated signaling, can give rise to pathological 
conditions.  
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In this thesis I will describe the work on the RTK Met and its specific ligand, 
Scatter Factor/Hepatocyte Growth Factor (SF/HGF), as a representative example of a 
large body of literature on a variety of RTKs. 
The scatter factors receptors have been shown to be required to mediate important 
processes during embryonic development, but their signaling, when deregulated, can also 
give rise to serious pathological disorders. Scatter factor ligands include Hepatocyte 
Growth Factor (HGF), which acts trough Met receptor tyrosine kinase, and Macrophage-
Stimulating Protein (MSP) which is the specific ligand for Ron receptor tyrosine kinase 
which shares extensive homologies with Met. Scatter factors are the main mediators of a 
complex process called invasive growth. This process combines cell proliferation with 
cell-cell dissociation and movement, extracellular matrix degradation and survival. 
Experiments carried out using loss of function mutants of either HGF or Met 
demonstrated that this ligand-receptor pair plays a key role during placenta and liver 
development (Uehara et al., 1995) (Maina et al., 1996) (Bladt et al., 1995) (Schmidt et al., 
1995). Phenotypic analysis of the mutants furthermore revealed an essential role for HGF 
and Met during cell migration and polarization (Brand-Saberi et al., 1996). Not 
surprisingly, the events that are modulated by scatter factors in normal cells are the same 
as those that foster the aberrant tendency of malignant tumors to start invasive growth. 
Transgenic animals expressing mutant constitutively active Met receptor develop 
mammary hyperplasia and metastatic carcinomas (Jeffers et al., 1998; Liang et al., 1996). 
More strikingly, the simple overexpression of the wild-type form of Met receptor in 
hepatocytes results in hepatocellular carcinomas (Wang et al., 2001). Accordingly, mice 
overexpressing HGF are characterized by the appearance of a broad array of metastatic 
neoplasms (Takayama et al., 1997a; Takayama et al., 1997b) (Otsuka et al., 1998). 
Variation in space and time, strength and duration, of a given receptor-mediated 
signal are clearly important parameters by which a cell is driven to either respond 
physiologically in controlling development, or aberrantly in driving disease-associated 
processes. In order to avoid errors, cells have developed mechanisms which ensure that 
appropriate parameters of a signal are received and maintained for the correct time. Thus 
the generation, tuning, and termination of a signal must be viewed as integrated processes 
that orchestrate in time and space the correct output of any given signal.   
Introduction 
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Negative receptor signaling 
 
As discussed above, even if some receptors convey inhibitory signals, many of 
them also mediate “positive” signals, either in a physiological or in an aberrant manner, 
involved in cell stimulation. In order to avoid errors in signaling, cells have developed 
mechanisms which counterbalance “positive” receptor-outputs to ensure that appropriate 
thresholds of receptor signaling is achieved and maintained for the correct length of time. 
These mechanisms are defined as “negative” signals.  
In most cases a receptor induces simultaneously “positive” and “negative” signals 
that appear to be functionally connected. A delicate balance between positive and 
negative signaling appears to be critical for normal cell homeostasis, and its deregulation 
is often implicated in developmental abnormalities and human diseases. 
 
Irreversible inhibitory signals  
 
Negative signaling results in the attenuation of signal transmission via a very 
complex chain of events occurring at various cellular levels, and can be categorized as 
reversible and irreversible.  
Irreversible inhibition of signaling is most commonly mediated by activation-
dependent protein degradation. Degradation of signaling proteins fulfill two different 
purposes: it terminates the signal by removing activated protein, and it generates a 
latency period in the cell before the next signaling events can be transmitted again. While 
many cytoplasmic signaling molecules are locally targeted for destruction in the 
proteasome, RTKs are also removed from the membrane’s surface via endocytosis and 
degraded in the lysosomal compartment. Many of the steps required for degradation of 
signaling molecules depend on protein ubiquitination, an evolutionary conserved 
modification, where a small protein, ubiquitin, is covalently bound to specific lysine 
residues on the target protein by families of enzymes called ubiquitin ligases (Pickart, 
2001). Proteins can be modified either by the addition of a single ubiquitin molecule 
(mono-ubiquitination) or by the addition of a chain of ubiquitins (poly-ubiquitination) 
and also by the addition of several single ubiquitin molecules (multi-ubiquitination). The 
Introduction 
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general consensus is that monoubiquitination is sufficient to drive internalization and 
endosomal sorting of the cell membrane receptor, whereas poly-ubiquitinied proteins are 
recognized by the proteasome which mediates protein unfolding and degradation (Hicke, 
2001) (Weissman, 2001). 
 
Cbl ubiquitin ligase 
 
Several ubiquitine ligases have been implicated in tyrosine kinase receptor 
ubiquitination. However, the Cbl family plays the most relevant role in ligand-induced 
receptor tyrosine kinase ubiquitination and therefore down regulation (Thien and 
Langdon, 2001). Cbl is an ubiquitine ligase that can be divided into distinct domains. 
Each domain interacts with multiple signal transducers, giving the molecule a 
multiadaptor characteristic as well (Fig.2A). Cbl contains a tyrosine kinase binding 
domain that interacts with activated tyrosine kinases of the receptor and non-receptor 
type; a RING domain which is responsible for the ubiquitine ligase activity; and a proline 
rich region critical for SH3-containing protein interaction. Cbl also contains tyrosine 
residues, that upon phosphorylation, can bind with SH2-containing proteins. Several 
RTKs such as EGFR, ErbB2, and Met are ubiquitinated upon binding to Cbl (Thien and 
Langdon, 2001) (Joazeiro and Weissman, 2000). However, more recent studies suggested 
that Cbl action is not limited to RTK ubiquitination. Cbl appears to play an active role in 
ligand-induced RTK endocytosis, contributing to RTK down-regulation via both modes. 
This has been described in two studies in which Cbl was shown to regulate RTK 
endocytosis by binding to a multiprotein complex (Soubeyran et al., 2002) (Petrelli et al., 
2002). One member of this complex, CIN85, has been proposed to act as a scaffolding 
protein. CIN85 is able to recruit signaling molecules into receptor-associated protein 
complexes critical for RTK trafficking (Dikic, 2002). Moreover, CIN85 was found to be 
constitutively associated with endophilins, a family of proteins that mediate the negative 
curvature of the plasma membrane, which is a critical step during endocytosis. The model 
proposed by these studies is that CIN85 via its SH3 domain is recruited to the receptor-
associated Cbl.  
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Figure 2. Cbl, a 
ubiquitin ligase and a 
multiadapator protein. 
The Cbl protein can be 
divided into distinct 
domains and each of 
them interacts with 
multiple signal 
transducers (A). The 
amino-terminal portion 
contains the tyrosine 
Kinase Binding (TKB) 
domain that interacts 
with activated Ttyrosine 
Kinases (TKs) of the 
receptor and non-
receptor type. The 
RING-finger domain is 
responsible for Cbl 
enzymatic activity. A 
polyproline-rich region (P-rich) is critical for interaction with SH3-containing proteins such as 
Grb2 or Src. The Cbl carboxyl terminus contains several tyrosine residues (Y) that, upon 
phosphorylation (P), interact with SH2-domain-containing proteins. It also contains a serine 
residue (S) that, when phosphorylated, binds to 14-3-3 protein. The binding site for the SH3 
domains of CIN85 is found in the distal carboxyl terminus of Cbl. CSFR1, colony-stimulating 
factor receptor. Cbl promotes receptor endocytosis and down regulation of activated RTKs (B). 
Once that Cbl is directly or indirectly recruited to the active RTK, the CIN85–endophilin (End) 
complex binds to the receptor-associated Cbl via SH3 interaction. Cbl controls from one side the 
endocytic process by recruiting CIN85-endophilin complex in the proximity of the receptor and 
from the other side the ubiquitination of RTKs and receptor-associated proteins. P, phosphate; 
Ub, ubiquitin. (modified from (Dikic and Giordano, 2003) 
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The binding stability between CIN85 and Cbl was found to be increased by 
ligand-induced Cbl phosphorylation. By these processes the receptor is then functionally 
associated with endocytosis-regulating molecules. Disrupting the Cbl-CIN85-endophilin 
complex, without affecting Cbl ubiquitin ligase activity, was sufficient to inhibit RTK 
endocytosis and degradation. Interestingly Cbl was found also to mediate EGF-induced 
ubiquitination of CIN85, which was important for EGF receptor degradation (Haglund et 
al., 2002). The binding of Cbl to activated RTKs thus control from one side the endocytic 
process by recruiting CIN85-endophilin complex in the proximity of the receptor and 
from the other side the ubiquitination of RTKs and receptor-associated proteins (Fig. 2B). 
The Cbl-mediated mechanisms are therefore more likely to dampen the signal 
transduction by removing the active receptor from the cell membrane rather than fine 
tuning the receptor-mediated signaling. 
 
 
Reversible negative signaling 
 
Transient inhibition tunes signal transduction by temporarily interfering with the 
strength and duration of the signal. Multiple mechanisms can contribute to reversible 
inhibition such as steric hindrance, compartmentalization of effectors, post-translational 
modification or inhibition of catalytic activity. Some of these mechanisms result in 
dampening of the entire RTK-mediated signal, directly affecting the receptors ability to 
transmit signals. Others appear to negatively regulate specific pathways downstream of 
RTKs, therefore resulting in the fine tuning of the final signaling output.  
 
Protein tyrosine phosphates 
 
Dephosphorylation of protein tyrosine kinases by protein phosphates is probably 
one of the most intensively studied mechanisms of RTK negative regulation. It is well 
recognized that Protein Tyrosine Phosphatases (PTPs) play a specific and active role in 
determining the levels of phospho-tyrosine within the cell and in the regulation of 
physiological processes (Mustelin, 2002) (Tonks and Neel, 1996) (Tonks, 1996). Recent 
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work has identified 107 genes that encode members of the protein tyrosine phosphatase 
family (Alonso et al., 2004). All PTPs have a conserved catalytic domain with phosphor-
tyrosine-specific phosphohydrolase activity responsible for the selective removal of 
phosphate groups from tyrosine residues located in specific phosphorylated proteins. 
Based upon the amino acid sequences of their catalytic domains, the PTP can be 
classified into four separate families each of which present a range of substrate 
specificity. 
Due to the complexity of the subject I will limit the description of PTPs to some 
of the better studied class I PTPs and their involvement in RTKs negative signaling.  The 
class I, in fact, constitutes by far the largest family; it contains the 38 well-known and 
characterized PTPs and the “dual-specific” phosphatases which are the most divergent 
class of phosphatases in terms of substrate specificity. The “classical” PTPs can be 
further divided into transmembrane, Receptor-like Protein Tyrosine Phosphatases (RPTP) 
and non transmembrane protein tyrosine phosphatases. Even if the class I PTPs are the 
better studied and characterized member of the tyrosine phosphatase family, one common 
features among all the PTPs is the presence of combinations of modular domains (Alonso 
et al., 2004). Many of these domains are responsible of protein-protein interaction or 
phospholipids binding modules, although many of the domains’ functions are still poorly 
characterized. The domains found in PTPs include modules that bind specific domains or 
motifs in other protein (phosphorylated or not), cellular membranes, the cytoskeleton, or 
specific phospholipids. It is interesting to note that the domains found in protein tyrosine 
kinases are substantially different from the ones found in PTPs. These differences in 
structure between protein tyrosine kinase and PTPs can reflect the need to regulate the 
two classes of enzymes in a temporally and spatially distinct and often reciprocal manner. 
 
RTK inhibition by protein tyrosine phosphatases 
 
Only two human non-receptor PTPs (SHP1 and SHP2) have SH2 domains 
organized in a tandem fashion, while no PTP contains SH3 domain. The presence of a 
SH2 domain in SHP1 and 2 suggested that these enzymes could be targets for recruitment 
by RTKs in order to switch-off signaling, presumably by dephosphorylation. Thus the 
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involvement of SHP1 and 2 in negative signaling was intensively studied. However, 
SHP2 phosphatase and its Drosophila Melanogaster homologue Corkscrew have been 
implicated in positive rather then negative signals by RTK (Perkins et al., 1992). On the 
other hand, a well characterized functional interplay between a PTP and RTK is elegantly 
demonstrated by the use of a naturally occurring SHP1 and Kit RTK loss of function 
mutant mice. Upon ligand stimulation SHP1 is recruited, via its SH2 domain, by Kit RTK 
(Yi and Ihle, 1993). Kit RTK is encoded by the Dominant White Spotting (W) locus in the 
mouse, while SHP1 by the motheaten (me) gene. Both mutants are characterized by 
haematologic defects, since SHP1 and Kit expression is mainly confined to 
haematopoietic tissues. Homozygosity for mutations in both W and me ameliorates 
aspects of both phenotypes, demonstrating that Kit RTK plays a role in the pathology of 
the me phenotype and, conversely, that SHP1 negatively regulates Kit signaling in-vivo 
(Paulson et al., 1996). Moreover, the negative signaling by SHP1 and its recruitment by 
the erythropoietin (EPO) receptor has been shown to be essential for the receptor 
physiological function. EPO receptor is devoid of intrinsic kinase activity but it can 
signal via phosphorylation by the non-receptor protein tyrosine kinase JAK2. The 
recruitment of SHP1 to the receptor appears to be essential in order for termination of 
EPO-mediated proliferation signals via dephosphorylation of JAK2 (Klingmuller et al., 
1995). Similarly, PTPs have been shown to play a major role in removing phosphate 
groups on auto-phosphorylation sites of RTKs located either in the kinase activation loop, 
therefore inhibiting the kinase activity, or in receptors docking sites, therefore 
inactivating specific signal transduction pathways (Hunter, 1995). As for RTKs, the most 
convincing evidence of the roles played by PTPs is arising from studies where the loss of 
a specific PTP is analyzed. For example the function of PTP1B (non-receptor tyrosine 
phosphatase, class I) has been investigated by destructing the gene in mice (Elchebly et 
al., 1999) (Klaman et al., 2000). These studies provided evidence that PTP1B is essential 
to negatively regulate the Insulin RTK signaling. The phosphorylation level of the Insulin 
Receptor, upon ligand stimulation, was found to be prolonged in the liver of mice lacking 
PTP1B compared to wild type mice. Moreover, these mice were found to be more 
sensitive to Insulin treatment in respect to wild types as measured by glucose uptake 
assays. Interestingly, the effects of the absence of PTP1B were found to be tissue specific 
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since the glucose uptake was found to be affected in the muscles but not in the adipose 
tissue of the mutant mice.  
Recent work provided images of spatial and temporal interaction between the 
non-receptor tyrosine phosphatase PTP1B and activated RTKs (Haj et al., 2002). This 
study illustrated how inactivation of RTKs can be spatially controlled by intracellular 
PTPs. Upon ligand activation, the RTKs are internalized to the endosomes, where they 
undergo limited dephosphorylation by PTP1B present in the endoplasmic reticulum. 
PTP1B therefore has been shown to specifically provide spatial limits on RTK activity.  
Finally, PTPs not only play a critical role in negatively regulating ligand-activated 
kinases, but it has further been demonstrated, by exposing cells to PTP inhibitors, that 
they are critical in maintaining the ligand-independent RTKs activation at low levels 
(Jallal et al., 1992). 
 
RTK signaling inhibition by protein tyrosine posphatases 
 
As mentioned before, the “dual-specific” phosphatases (DSPs) of the Class I 
phosphatases are the most divergent group of phosphatases in terms of substrate 
specificity (Alonso et al., 2004). 11 of the 61 DSPs encoded by the human genome are 
specific for the mitogen-activated kinase (Map kinase) Erk, JNK and p38 kinase (Keyse, 
1998) (Saxena and Mustelin, 2000). These are all critical signaling pathways activated by 
most RTKs. Map kinase phosphatases are all characterized by dual phosphothreonine and 
phosphor-tyrosine specificity and the presence of a Map kinase targeting motif (Alonso et 
al., 2003; Bordo and Bork, 2002). These enzymes contribute in regulating specific signals 
downstream of RTK-activated signaling pathways. 
Finally, another well characterized sub-class of PTPs is represented by the 
phosphatase and tensin homologue (PTEN) genes. These enzymes specifically 
dephosphorylate inositol phospholipids (PIs). The PIs, membrane-associated 
phospholipids known to regulate many biological processes, play a crucial role in the 
RTKs-mediated signal transduction. Different PIs are localized in distinct plasma or 
endosomal membrane compartments and are involved in the regulation of membrane 
dynamics by their ability to interact with signaling molecules containing PI-binding 
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domains. The cellular levels of PIs vary as a consequence of stimuli-dependent 
phosphatidyl-inositol kinases and phosphatases whose enzymatic balance maintains a 
correct threshold of PIs-mediated signaling. PTEN is a ubiquitously expressed 
phosphatase specific for the 3’ position of the inositol ring. It has a tumor suppressor 
activity, indicating its important role in growth inhibition pathways. Furthermore, PTEN 
loss of function mutant mice die embryonically, while high tumor frequency is observed 
in heterozygosis (Suzuki et al., 1998). These findings show PTEN to specifically down-
regulate the RTK-mediated phosphatidyl-inositol kinases activation pathway. 
Although the role of PTPs in the regulation of signal transduction is still under 
intense investigation, taken together the available data indicate that PTPs play an 
important role in regulating the level of tyrosine phosphorylation in the cell opposing 
their enzymatic activity to the protein tyrosine kinases one, thus controlling specific 
RTK-mediated biological functions through negative signaling. 
 
Negative signaling via adaptor proteins:  
 
APS, SH2-B, Lnk  
 
Over the past years a number of adaptor proteins have been identified as part of 
the RTKs inhibitory machinery. These molecules contain several protein-protein 
interaction domains that are generally responsible for the recruitment of inhibitory 
molecules (such as Cbl) to the proximity of the receptor, therefore coupling the receptors 
with their own inhibitory pathways. APS, SH2B and Lnk form a conserved family of 
adaptor proteins, whose members share several conserved domains such as a proline-rich 
putative SH3 binding motif, a plextrine homology domain (PH domain), several potential 
tyrosine phosphorylation sites and a SH2 domain which suggest a role in kinase-mediated 
signaling. This role is supported by the evidence that these adaptors specifically bind to 
activated RTKs (Riedel et al., 1997) becoming substrate for receptor-mediated tyrosine 
phosphorylation (Ahmed et al., 1999; Kotani et al., 1998). Mice lacking Lnk show 
increased B-cell production due to over-proliferation of the B-cell precursors in response 
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to Stem Cell Factor (SCF), the specific ligand for Kit RTK (Takaki et al., 2003). Thus 
Lnk negatively modulates c-Kit RTK and plays a critical role in B-cell and 
haematopoietic development via a mechanism that is still not clear. In contrast, despite 
the significant structural homologies in the members of the family, SH2-B has been 
shown to be required in-vivo for proper development of the gonadal organs possibly by 
positively regulating the Insulin Growth Factor-like receptor (IGF-I) (Ohtsuka et al., 
2002). The third member of the family, APS, has been shown to associate with and to be 
phosphorylated by several receptors including the Insulin Receptor and the receptor for 
Nerve Growth Factor (NGF), TrkA (Moodie et al., 1999) (Qian et al., 1998). Loss of 
function mutant mice for APS displayed an increased number of a B-cell subset resulting 
in over-production of a specific antibody. Even if the molecular mechanisms by which 
the members of the family work are poorly understood, several studies suggested that at 
least APS exerts its inhibitory function through the recruitment of Cbl in the proximity of 
the activated receptor, thus promoting ligand-dependent receptor ubiquitination (Ahmed 
et al., 2000) (Wakioka et al., 1999). 
 
 
Figure 3 Aps recruit Cbl to the 
activated insulin receptor.  
Potential signaling complexes 
generated by APS after stimulation 
with Insulin. Aps recruits Cbl and 
Cbl-associated proteins to the 
active Insulin receptor. This results 
in the ligand-dependent 
ubiquitination and degradation of 
the receptor.P, phosphate. Ub, 
ubiquitin.   
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SLAP (Src-Like-Adaptor-Protein) 
 
SLAP provides another example of an adapter protein involved in negative 
regulation of specific RTKs. It has been named due to the high similarity of its SH2 
domain to the one of Src family kinases. The Src-family kinases are non-receptor tyrosine 
kinases recruited and activated by a number of RTKs. Upon ligand stimulation several 
RTKs transmit via Src recruitment and activation, critical proliferative signals. SLAP 
contains an SH2 domain, an SH3 domain and a 100 amino acid unique C-terminal tail. 
By overexpression studies SLAP was found to inhibit PDGF-RTK-mediated proliferative 
signal, while depletion of the protein, via antibody microinjection, resulted in over-
proliferation upon Platelet-Derived Growth Factor (PDGF) or serum stimulation (Roche 
et al., 1998). Since SLAP and Src share the same tyrosine docking site on PDGF receptor 
and co-localize in cells and since the SH2 domain of SLAP was found to be required for 
SLAP inhibition of PDGF-RTK-mediated proliferative signals, SLAP was thought to act 
via competing with Src for the binding to the activated receptor (Fig.4). However, 
investigating SLAP inhibition of PDGF-mediated proliferative response in an excess of 
Src kinase condition, this model appeared to be not completely correct (Manes et al., 
2000). The picture that is emerging from this data is that SLAP is recruited to the 
activated receptor via its SH2 domain and competes partially with Src kinase for the 
association with the receptor. On the other hand SLAP SH3 domain is able to bind 
specific Src effectors, sequestering them from further interactions and signaling, and this 
may explain why in the presence of Src excess SLAP is still able to inhibit proliferation 
downstream PDFG receptor (Fig.4). Therefore this model proposes that SLAP acting via 
its SH2 domain competes with Src for the binding of activated receptor. It also acts via its 
SH3 domain, sequestering specific Src effectors and thus inhibiting specific signaling 
pathways activated by the receptor through Src recruitment. 
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Figure 4. SLAP inhibits 
PDGF-mediated proliferative 
signals. 
SLAP is recruited in the 
proximity of the activated 
PDGFRr and competes, via its 
SH2 domain, with Src for the 
binding to phosphorylated 
tyrosines. The SH3 domain of 
SLAP, on the other hand, 
sequesters Src-specific 
effectors resulting in the 
inhibition of Src-specific 
signaling pathway. 
 
 
 
 
 
Grb2 
 
The mechanism of stimulation-dependent receptor ubiquitination has been also 
proposed to be mediated by the adaptor protein Grb2. Grb2 contains one SH2 domain 
through which it binds to several RTK specific phospho-tyrosines and two SH3 domains 
that link the receptor-Grb2 complex to downstream effectors. The most widely studied 
among Grb2 interactors is the Ras Guanine Nucleotide Exchanger Sos. The ligand-
dependent recruitment of Grb2 by RTKs leads to the activation of Sos/Ras pathway that 
in turn activates various other signaling proteins to relay the signal downstream along 
several pathways. The SH3 domain of Grb2 can also bind Cbl ubiquitin ligase therefore 
indirectly recruiting Cbl to activated RTKs such as Met or EGFR (Waterman et al., 2002) 
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(Peschard et al., 2001; Peschard et al., 2004). Additional evidence that Grb2-Cbl 
interaction is important for negative regulation of RTKs is provided by genetic studies in 
the nematode C.elegans, where SLI-1, the orthologue of Cbl, is able to restore the 
phenotype due to loss of function mutation in LET-23 gene (orthologue of EGFR), and 
for this function SEM-5, the orthologue of Grb2, is required (Yoon et al., 1995). Since 
Cbl and Sos form exclusive complexes with Grb2, Cbl may compete with Grb2 for Sos 
binding, thus further inhibiting Ras activation.  
Grb2 is also able to bind other signaling inhibitors such as Ack and SOCS 
(Hopper et al., 2000) (De Sepulveda et al., 1999). Acks (Activated Cdc42-associated 
tyrosine Kinase) are a non receptor tyrosine kinase family whose function in mammalian 
cells remains elusive. Acks contain several domains including a SH3 domain a CRIB 
domain (Cdc42/Rho Interacting Binding) and a number of potential Map kinase 
phosphorylation sites. A genetic study in the nematode C.elegans suggested that sem5 
(the orthologous of Grb2) inhibits LET23-(orthologous of EGFR) mediated biological 
function via the recruitment of inhibitors such as Ark-1, the Ack orthologue (Hopper et 
al., 2000). 
 Furthermore Grb2 is able to bind SOCS (Suppressor Of Cytokine Signaling), 
another adaptor protein that has been shown to be involved in negative receptor signaling. 
Forcing the expression of SOCS in haematopoietic cells result in a strong and specific 
decrease of Kit RTK-mediated proliferation, while cell survival was not affected (De 
Sepulveda et al., 1999). One of the particular characteristics of the model proposed by 
these studies is that SOCS has also been shown to be transcriptionally up-regulated by the 
Kit ligand. Thus, Grb2 appears to recruit SOCS, an inducible switch, to the active 
receptor leading to the negative modulation of proliferative signals in favor of cell 
survival signals. 
Taken together these data picture Grb2 as an adaptor protein able to integrate both 
positive and negative signals by activating Ras pathway via Sos and by attenuating RTK 
signaling via the recruitment of different negative regulators (Fig.5).  
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Figure 5. Multiple functions of Grb2. 
The adaptor protein Grb2 may serve as a regulated scaffold for the binding of other signaling 
proteins that include both positive (Sos) and negative (Ack, SOCS, Cbl) regulators. Grb2 can link 
RTKs with activation of Ras/MAPK pathway via its association with Sos, while it promotes 
receptor ubiquitination and endocytosis by binding to the Cbl-CIN85-endophilin (End) complex. 
Grb2 can also recruits Ack to further attenuate signaling pathways. Furthermore, Grb2 can 
recruit SOCS, which transcription is activated by the receptor itself, to the active receptor. This 
leads to the negative modulation of proliferative signals in favor of cell survival signals. P, 
phosphate, Ub, ubiquitine 
 
 
Negative signaling via Feedback loops 
 
Several of the adapters found to be involved in negative regulation of RTKs 
signaling are expressed in the context of transcriptional responses activated by the RTK 
itself. In other words the RTK mediates the transcriptional activation of negative 
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regulators of the RTK itself. This mechanism is used by the cells to adjust receptors 
output in response of monitoring their own activity.  These events are defined as feed-
back loops. Recently it has become clear that the principles of feedback, both positive 
and negative, are indeed widely used to produce the signaling properties required for a 
proper overall signaling output that is necessary in physiological processes. Negative 
feedback loop occurs when for example a signal induces the expression of its own 
inhibitor; it serves to dampen and/or to limit the signal. Positive feedback occurs when a 
signal induces more of itself, or another molecule that amplifies the original signal and it 
serves to stabilize, amplify, or prolong the signaling. The widespread use of feedbacks 
and the variety of its consequences make it an important principle of regulating signals 
from RTKs.  
Negative feedback loops are used in several processes. For the purpose of this 
thesis I will describe some examples that well illustrate the strategies in which feed back 
loops participate, pointing-out the relevance of known negative feedbacks during 
physiological processes and their relevance in diseases. Thus, I will particularly focus on 
experimental demonstration of the involvement of negative feedback loops that are either 
directly acting on RTKs or in the proximity of their signal transduction rather then 
describing the better studied and characterized negative feedbacks in the context of 
transcription factor regulation (Smolen et al., 2000).   
The most common use of negative feedback is to limit the duration of a signal. In 
a straightforward model it occurs when a signal induces its own negative regulator so that 
when a given signal reaches a certain threshold the signal is terminated. Feedback loops 
are also involved during development when a receptor/ligand has to exert its biological 
function in a limited space, close to the source of the signal, without affecting more 
distant cells. In this case the negative feed back loop is involved in spatial control of a 
signal. On the other side pattern formation is an event during development where positive 
and negative feedback must integrate their information in order for the cells to respond 
properly. The establishments of left and right asymmetry, anterior/posterior compartment 
boundaries, dorso/ventral axes are all critical events during development controlled by 
the coordinated integration of positive and negative feedback loops.  
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Limiting the duration of a signal 
 
There are several examples of such a use of negative feedback loops; interferon 
signaling describes well the importance of these negative signaling events in 
physiological processes.  
The interferon family consist of two main groups: the type I interferons include 
interferonα and interferonβ, whereas interferonγ is the only type II interferon (Billiau, 
1996). Interferonγ acts by binding to and inducing the multimerization of a cell surface 
transmembrane receptor composed by IFNGR1 and IFNGR2 (Hemmi et al., 1994) 
(Novick et al., 1994). This results in the activation of the signaling pathways that drives 
the expression of a variety of genes involved in activation of macrophages, antiviral and 
antiproliferative responses (Boehm et al., 1997). The Interferonγ is a key player in 
coordinating resistance to infections (Boehm et al., 1997; De Maeyer-Guignard et al., 
1993) but its actions are not always beneficial since the infections might elicit in the host 
responses of sufficient magnitude to become life threatening. Experiments by which the 
Interferonγ levels were experimentally elevated in neonatal mice showed the potentially 
toxic effect of interferonγ signaling, including fatty degeneration of the liver (Toyonaga 
et al., 1994) (Gresser, 1982). The genes that are transcriptionally regulated by the active 
receptor include a family of molecules that can terminate the signal (Starr et al., 1997) 
(Endo et al., 1997). These molecules such as SOCS are involved in negative feedback 
loops. The physiological importance of this feedback mechanism is well exemplified by 
the characterization of SOCS function in vivo. SOCS1 loss of function mutant mice die 
perinatally by a complex neonatal disease, exhibiting excessive responses to 
Interferonγ signaling (Brysha et al., 2001). Although the mechanisms by which SOCS1 is 
able to inhibit interferon signaling are not completely clear, there is evidence indicating 
that in this context, SOCS acts as a pseudo-JAK substrate targeting the active JAK kinase 
for degradation, therefore terminating the signal. In these studies SOCS1 appears to be an 
inducible key modulator of Interferonγ actions allowing the benefic effects of this 
cytokine to occur without the risk of associated pathological responses.  
Another example of such a negative feed-back loop is represented by Mig6 
(Mitogen Inducible Gene 6) adaptor protein. Mig6 shows in its protein sequence 
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extensive homologies with the non receptor tyrosine kinase Ack which was found, as 
mentioned before, to inhibit EGFR-mediated biological function in C. Elegans. Mig6 was 
isolated as a protein interacting with ErbB2 and was shown to be induced by ErbB 
ligands (Fiorentino et al., 2000). The predicted structure of this molecule consists of 
several conserved domains. Among these the CRIB domain, a putative SH3 binding 
motif, a putative clathrin binding motif and a nuclear localization signal (Makkinje et al., 
2000). Overexpression studies suggested that Mig6 is a selective inhibitor of ErbB2 
proliferative responses (Fiorentino et al., 2000) (Hackel et al., 2001) as part of a negative 
feedback loop. Accordingly, Mig6-specific siRNA transfection or micro-injection of anti-
Mig6 antibodies into growth factor-stimulated fibroblasts enhanced the mitogenic activity 
of ErbB2 receptor suggesting that Mig6 is part of a physiological negative feedback 
mechanism of ErbB receptors (Fiorini et al., 2002; Xu et al., 2005). The mode by which 
Mig6 is able to inhibit receptor-mediated proliferative responses is not clearly 
understood, however due to its ability to bind ErbB2 and EGFR, Mig6 was proposed to 
interfere with the signaling as a receptor-proximal inhibitor (Hackel et al., 2001) 
(Fiorentino et al., 2000). The ability of Mig6 to interfere with ErbB2 biological function 
has been proposed to depend on the direct binding observed between Mig6 and several 
receptor-proximal signaling molecules such as Grb2. Furthermore, upon ectopic 
expression of Mig6 in murine fibroblasts ErbB2-mediated map kinase activation was 
found to be altered. Interestingly, under these conditions, Map kinase activation was 
found to be affected by Mig6 overexpression at the late (3-9 hours upon ligand 
stimulation), but not the early time point of ligand activation (Fiorentino et al., 2000). 
However, more recent overexpression data using a mutant version of Mig6 lacking the 
ErbB binding region suggested that Mig6 can antagonize mitogenic signals further 
downstream of activated ErbB receptors (Anastasi et al., 2003). Thus, the mode of action 
of Mig6 has been proposed to be a scaffold/adaptor protein able to recruit and interfere 
with the time course and strength of activation of several signaling molecules critical for 
receptor-mediated proliferative response.   
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Spatial control of the signal by negative feedback loop  
 
The biological significance of the negative feedback loop was demonstrated in 
studies on the cell fate mediated by EGFR and its antagonist Argos. Argos is a soluble 
molecule that carries a modified EGF domain and is able to bind the extracellular domain 
of DER (EGFR orthologue in drosophila) as a pseudo-ligand. Argos is then able to 
compete with Spitz, the main activator of DER, for receptor binding. The binding of 
Argos to DER receptor results in receptor inactivation. Therefore Argos is an 
extracellular inhibitor of DER (Freeman, 1997). It has been shown that Argos expression 
is dependent on DER activation, therefore forming a negative feed-back loop (Fig.6A). 
The roles of DER, spitz and Argos have been extensively investigated in several 
organisms. The best picture of spatial control mediated by this negative feed back loop is 
certainly arising from studies conducted in the drosophila eye (Freeman, 1998). The fly 
eye is formed by 750 facets, or “ommatidia”. Each ommatidium contains the same set of 
specified cells and presents the same internal structure that develops from a monolayer 
epithelium called the eye immaginal disk. DER is essential for the formation of all the 
cells in the ommatidium. This is supported by two observations: the first is that Spitz (the 
main activator of DER) is required for the formation of all the photoreceptors, the second 
is that Argos (the Spitz antagonist) loss of function leads to over-recruitment of 
photoreceptors and consistent with this, its overexpression leads to a reduction in their 
number. In the early ommatidium, active Spitz is produced in the three earliest and 
centrally located cells (Fig.6B,C). This leads to DER activation in the neighboring and 
undifferentiated cells. The neighboring cells are in this way determined for 
differentiation. Each cell that is activated by Spitz ligand up-regulate Argos. Argos is then 
secreted and has the ability to diffuse further away compared to the secreted Spitz 
(Freeman et al., 1992), thus blocking more remote cells from responding to the ligand. 
Argos is however, unable to inhibit the effect of Spitz in cells that are exposed to high 
concentration of ligand (cells close to the source of Spitz) or to cells that are already 
committed to differentiation (Freeman, 1998). This mechanism is therefore limiting the 
effective range of Spitz action and thereby the number of cells that are recruited to the 
developing eye (Fig. 6 B,C). 
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Interestingly the EGF receptor action can be inhibited by different inhibitory 
molecules. The inhibitors Argos, Sprouty and Kekkon are all regulated by EGFR taking 
part in negative feedback loop. Importantly it appears that these different negative EGFR 
regulators have all different biological functions (Fig. 6A). For example Argos is a 
secreted EGFR extracellular inhibitor that can act at long range distances (Freeman et al., 
1992) (Schweitzer et al., 1995), Sprouty is a more general intracellular signaling inhibitor 
that can act downstream several RTKs (Casci et al., 1999) and Kekkon is a EGFR specific 
transmembrane inhibitor that act only locally on the cell that expresses it (Ghiglione et 
al., 1999). Accordingly the loss of function mutants of Argos, Sprouty and Kekkon in 
Drosophila show different phenotypes. This evidence supports the idea that different 
negative regulators are not redundant but rather specific in regulating different receptor-
mediated biological functions.  
 
 
Figure 6. Multiple feedback loops 
regulate the Drosophila EGF receptor.  
There are three known feedback inhibitors 
(shown in red) of the fly EGF receptor 
(Egfr), which 
signals through Ras: Sprouty (Spry), 
Kekkon-1 (Kek-1) and Argos (A). Each of 
which have different biological functions. 
(B,C) A model of ommatidial development. 
Ommatidia of increasing maturity are 
shown from left to right; (B) the 
recruitment of photoreceptors and (C) 
cone cells. Blue cells are the source of 
Spitz and they are able to recruit the 
neighboring yellow cells at each stage, but 
are unable to trigger the more remote grey cells, which are inhibited by Argos. Argos is 
expressed by each cell as it is determined. Because of its long range of action (see text), it may be 
more accurate to think of it usually forming a ‘sea’ of inhibitor surrounding all the developing 
ommatidia (Modified from Freeman et al.,2000 and Freeman et al.,1997). 
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Met and HGF  
 
Met Receptor tyrosine Kinase was first identified as an oncogene (Cooper et al., 
1984). This proto-oncogene was found to be a receptor tyrosine kinase but the ligand was 
not known (Park et al., 1986). Independently, two different experimental approaches 
identified a potent motogenic factor (Scatter Factor, S.F.) (Stoker et al., 1987) and a 
factor that was strongly promoting mitogenesis in hepatocytes (Hepatocyte Growth 
Factor, HGF) (Nakamura et al., 1989). These factors were found to be the same molecule, 
which is referred to as HGF/SF (Gherardi and Stoker, 1990). Then further studies 
identified HGF/SF as the high affinity ligand for Met receptor tyrosine kinase (Bottaro et 
al., 1991). HGF/SF, together with the Macrophage Stimulating Protein (MSP), belongs to 
the Plasminogen family of proteins. Plasminogen is a circulating pro-enzyme that is 
responsible, in its active form, for the lysis of blood clots. The Plasminogen family 
members are characterized by the presence of at least one domain known as the kringle 
domain, a serine protease domain and an activation domain located between the kringle 
domain and the serine protease domain. HGF and MSP are unique members of the 
plasminogen family since they lack catalytic serine protease activity due to mutations in 
essential amino-acids. Like the plasminogen, HGF and MSP are synthesized and secreted 
as a single chain, mainly inactive precursors; they are further proteolitically converted 
into their active, disulphide-linked heterodimers in the extracellular matrix. Once 
secreted, the conversion from the inactive single-chain to the active two-chain 
heterodimer is effected by several serine proteases present in the extracellular matrix. 
HGF has also been shown to bind heparan-sulfate-proteoglycans with high 
affinity, which limits the diffusion of the factor in-vivo (Schwall et al., 1996) (Hartmann 
et al., 1998). The biological activity of HGF depends solely on its receptor Met, which 
like HGF, is a disulphide-linked heterodimer. The mature form of the receptor molecule 
is composed by one short extracellular α chain and a longer transmembrane β chain. The 
β chain presents a transmembrane domain, a tyrosine kinase domain, and a unique 
bidentate docking site which comprises two tyrosines that are essential for the Met-
mediated biological functions (Maina et al., 1996) (Ponzetto et al., 1994). The bidentate 
docking site contains in fact two tandem tyrosines in a degenerate motif, which when 
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auto-phosphorylated by the active receptor, bind different SH2-containing molecules 
such as PI3 kinase, Grb2 and the multiadaptor Gab1 (Furge et al., 2000). In-vivo 
mutations in the two tyrosines lead to an embryonic lethal phenotype resembling that of 
the HGF/Met null mutants, indicating that the overall biological effects mediated by the 
receptor is mainly transduced by this multifunctional docking site. Several cytokines and 
growth factors can induce cell proliferation, differentiation, motility, protection from 
apoptosis and in some circumstances they may contribute to the onset and maintenance of 
invasive growth. However, the disruption of growth constrain, acquisition of a motile 
phenotype, resistance to programmed cell death and the orchestration of several steps 
during this processes are optimally accomplished by HGF (Fig.7). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7. Biological functions mediated by the bidentate docking site of the Met receptor. 
Met receptor bidentate docking site contains two tyrosines embedded in a degenerate motif 
which, upon phosphorylation, can bind an array of signaling molecules such as Grb2, the p85 
subunit of PI3K and the multiadaptor Gab1. The two tyrosines are essential in order to mediate 
the entire array of Met biological function 
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Met signaling during development 
 
The phenotype analysis of HGF and Met mutant mice has shown that this ligand-
receptor couple plays essential roles in controlling several processes during mammalian 
development (Schmidt et al., 1995); (Bladt et al., 1995; Uehara et al., 1995); (Maina et 
al., 1996; Maina et al., 2001). These studies suggested that the function and the responses 
evoked by HGF/Met are complex and therefore they are not restricted to a single step 
during development. Met and HGF are expressed in a variety of organs during 
development. They provide essential signals for the survival and proliferation of 
hepatocytes and placental trophoblasts. Consistently the liver of null mutant of both HGF 
and Met is considerably reduced in size due to a decreased proliferation and increase in 
apoptosis of hepatocytes (Fig.8C,D). The loss of function mutant embryos of both Met 
and HGF die in uterus due to a defect in placental development (Fig.8A,B). However, 
these genetic studies showed a striking role for HGF and Met in regulating cellular 
motility. During development cells often migrate over long distances to their final target 
where they differentiate to form organs and tissues. These precursor cells initiate invasive 
growth by budding off from their primitive place of origin to migrate along 
chemotractant gradients and eventually differentiate to specify the architecture of a newly 
formed organ. For example, an important class of skeletal muscle is derived from long-
range migratory progenitors. The muscle progenitors delaminate (a phenomenon referred 
to as epithelial-mesenchimal transition) from an epithelial structure called 
dermomyotome which forms part of the developing somite. In mice, precursors of the 
limb, diaphragm, and the tip of tongue muscles migrate from the dermomyotome to their 
final location where they differentiate to form skeletal muscles. Null mutant mice for 
HGF or Met are completely devoid of muscle in the limb, diaphragm and tip of the 
tongue, highlighting the essential role played by Met and HGF in driving this 
“physiologically occurring” invasive growth (Fig8E-H). This phenotype was 
demonstrated to arise from a lack of epithelial-mesenchimal transition which results in a 
defect in the delamination of muscle precursors from the dermomyotome and secondly 
from a deficiency in cell migration. 
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Invasive growth plays also a relevant role during the development of the central 
and peripheral nervous system. The precisely controlled directional movement of axons 
and neurites following attraction or repulsive signals that guide them towards the target is 
crucial for the formation of the adult brain. Not surprisingly, HGF, secreted by the limb 
mesenchyme, was found to be a chemo attractant factor for motor neurons. The limb 
mesenchyme derived from wild type, but not from HGF-null mutants, was found to be 
able to induce axonal outgrowth from spinal cord culture. Consistent with this in-vitro 
observation, axons emerging from limb-innervating motoneurons of Met and HGF null 
mutant embryos show a significant decrease in neurite length (Fig.8I,J). Finally, not only 
does Met and HGF induce motoneurons axonal outgrowth but they also induce 
differentiation, survival and axonal outgrowth of sensory and sympathetic neurons in-
vivo (Maina et al., 1998). 
 
Figure 8. Met mediates a variety of biological functions. 
Comparison of wild type (A,C,E,G,I) versus Met loss of 
function mutant embryos (B,D,F,H,J). The placenta 
morphology of E13.5 loss of function (B) and wild type (A) 
embryos. (C,D) Increase in apoptosis (TUNEL staining, 
brown dots) of the hepatocytes of Met mutant embryos (D) 
compared to wild type (C). (E,F) In-situ hybridization 
analysis using a Met specific probe. Absence of myoblasts 
migration in the Met loss of function (E10.5, F) compared to 
wild type (E). The arrowheads (E) indicate a normal pattern 
of migrating myoblast precursors in wild type embryos. (G,H) 
section of the diaphragm (d) stained with phalloidin. In the 
Met loss of function mutants (H) a stippled line indicates the 
position where the diaphragm should be. The arrows (G) 
indicate the thickness of the wild type diaphragm. lu: lung, li: 
liver. (I,J) Whole mount anti-neurofilament staining of E12.5 
embryos (forelimb and thorax, dorsal up, anterior left). 
Arrowheads in I indicate branches of the Nervus 
thoracodorsalis. Scale bar is 0.6 mm. Note the absence of neurite branches in the Met loss of 
function embryos (J) compared to wild type (I). (Modified from Maina et al., 2001) 
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Met and HGF in pathological conditions 
 
Deregulation of Met and HGF system has been shown to be associated with 
several pathological conditions and has emerged to be a crucial feature of many human 
malignancies. This evidence is supported by several experimental approaches: first 
mouse and human cell lines that are overexpressing Met and HGF become tumorigenic 
and metastatic when injected in mice (Rong et al., 1994). Accordingly the down-
regulation of Met or HGF expression in human tumor cells decreases their tumorigenic 
potential (Abounader et al., 2002). Second, mice which overexpress Met or HGF as a 
transgene develop different types of tumors and metastatic lesions (Takayama et al., 
1997b). Third, there is unequivocal evidence that Met is implicated in human cancer  
with the Met kinase domain having activating mutations in both sporadic and inherited 
human renal papillary carcinomas (Danilkovitch-Miagkova and Zbar, 2002) (Park et al., 
1999). 
 
Met-mediated branching morphogenesis 
 
As mentioned above among many biological activities, branching morphogenesis 
and invasion appear to be the most prominent and complicated cellular events induced by 
HGF/Met. Notably, in fact, HGF/Met is one of the very few ligand/receptor couples that 
can induce branching morphogenesis. These series of events are crucial steps during 
pattern formation in many organs and tissues including, placenta, kidney, lung, mammary 
glands and nervous system. Branching morphogenesis is typically mediated through 
changes in cell shape, asymmetric polarization of the cell in the direction of branching, 
branch elongation, cell-cell contact and migration. Some of these Met-mediated 
biological functions can be recapitulated in-vitro by culturing dissociated cells. Met 
activation induces proliferative and anti-apoptotic responses in different cell lines. 
Epithelial cells, and in particular the Madin-Darby Canine Kidney (MDCK) cell line or 
the hepatocytes precursors cell line called MLP29, respond to Met activation by 
“scattering”, which is colony dispersal with an increase in motility. Moreover when these 
cells are cultured within a collagen matrix and treated with HGF, they form branched 
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tubules. Tubular branching is the in-vitro read-out for branching morphogenesis since it 
represents a complex phenomenon which requires tight coordination and regulation 
between cell growth, polarity and motility (Vande Woude G.F., 1997). 
Several studies used these in-vitro assays as read-outs in order to dissect the 
complexity of HGF/Met-mediated signaling and biological function. As mentioned 
before one of the characteristic of Met receptor is the presence of a bidentate docking site 
where two crucial tyrosines are inserted in a degenerate motif. Following ligand-induced 
receptor stimulation these two tyrosines become phosphorylated and promiscuously 
recruit an array of molecules. These include phosphatidyl-inositol 3 kinase (PI3K), the 
non receptor tyrosine kinase Src, the adaptor protein Grb2 and Shc (and the multiadaptor 
protein Gab1, which in turn can bind, among others, phospholipase Cγ (PLCγ), the 
protein tyrosine phosphatase SHP2 and the transcription factor STAT3 (Zhang and 
Vande Woude, 2003) (Trusolino and Comoglio, 2002) (Furge et al., 2000). This motif 
can recapitulate the entire signaling requirement for execution of the invasive growth 
program and branching morphogenesis. When the two multifunctional tyrosines are 
converted into phenylalanine, cells become completely unresponsive to HGF in-vitro 
(Ponzetto et al., 1994). The formation of branched tubules has been related to the 
sustained GAB1 phosphorylation and to the GAB1-mediated recruitment of PLCγ and 
SHP2, together with activation of the STAT pathways. Furthermore the mutation of the 
multifunctional binding site into preferential consensus for Grb2 or PI3K has allowed the 
dissection of the individual transduction pathways that are responsible for the oncogenic 
versus migratory effect of Met. Increasing the activation of Ras signaling by mutations 
that duplicate the Grb2 binding site increases the ability of Met to transform the cells, but 
abolishes the metastatic potential. On the other hand the optimizations of PI3 kinase 
binding results in enhanced invasion, but even in this case the metastatic potential of Met 
is abrogated. The full metastatic potential is restored only when both the effectors can be 
recruited to the kinase (Bardelli et al., 1999). These results strongly suggest that the 
concomitant activation of Ras/Map kinase and PI3 kinase pathways in addition to the 
recruitment and phosphorylation of the multiadaptor GAB1 are all essential steps of 
HGF/met-mediated morphogenic activity. 
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Met-mediated cytoskeleton rearrangement: Rho GTP-binding proteins 
 
One of the most crucial events during branching morphogenesis and epithelial-
mesenchimal transition is the conversion of the cell from an immobile to a migratory 
phenotype. This process requires an extensive remodeling of the cell cytoskeleton 
(Mitchison and Cramer, 1996) (Labouesse, 2004). Members of the Rho small GTP-
binding proteins, such as Rho, Cdc42 and Rac, play an important role in the process 
regulating actin cytoskeleton (Hall, 1998). GTPase of the Rho family critically modulate 
the establishment of epithelial polarity by regulating cell-cell junction assembly and 
cytoskeleton reorganization. It has also been shown that this family of proteins plays an 
important role during cell migration. In fact, upon receiving a fruitful signal to migrate, 
the cells orchestrate cytoskeletal remodeling and changes in the cell adhesive properties  
(Fig.9) (Fukata and Kaibuchi, 2001). By the use of loss and gain of function approaches, 
in numerous cell types, it has been established that Rho regulates the assembly of 
contractile actin filaments, while Rac and Cdc42 regulate the polymerization of actin to 
form peripheral lamellipodial and filopodial protrusions respectively (Nobes and Hall, 
1995) (Ridley and Hall, 1992) (Ridley et al., 1992). It is not really surprising that the 
Rho-family of GTPases play a critical role during cell migration and therefore in 
branching morphogenesis and epithelial-mesenchimal transition (Labouesse, 2004) 
(Portereiko et al., 2004) (Schumacher et al., 2004) (Smallhorn et al., 2004). While Rho 
has been shown to regulate the contraction-retraction forces required in the cell body and 
at the rear, it has been shown that Rac is required at the front of the migrating cell to 
regulate actin polymerization and membrane protrusions. Rac activity appears to be also 
regulated in space so that a gradient of active Rac can be visualized with the highest 
concentrations at the leading edge (Kraynov et al., 2000). Also Cdc42 induces actin 
polymerization to generate filopodia protrusions at the leading edge (Nobes and Hall, 
1995). However, recent studies on Drosophila suggest that Cdc42 is not required for 
migration per se (Sepp and Auld, 2003). Cdc42 does however play a critical role in 
controlling the direction of the migration and in defining cellular polarity in respect to the 
extracellular environment (Ridley, 2001) (Fig.9).  
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Figure 9. Acquisition of a motile and invasive phenotype by an adherent epithelial cell. 
Rho GTPase function is required for both the establishment of a fully polarized state (left) and a 
motile phenotype upon epithelial-to-mesenchymal transition (EMT; right). Movement involves a 
number of individual steps which include the following: loss of cell– cell adhesion, membrane 
protrusions in the direction of movement, de-adhesion from the extracellular matrix in the rear 
and re-adhesion in front, contraction of the actin cytoskeleton in order to move the body of the 
cell, and active remodeling of the extracellular matrix (ECM) by proteolysis and secretion. These 
steps also depend on alterations in the transcriptional profiling of the cell. (Nuc, nucleus; DES, 
desmosomes; TJ, tight junction; AJ, adherens junction) (From Schmitz et al., 2000). 
 
 
The polarized migration of many cells is reflected in the reorganization of 
microtubule cytoskeleton and centrosome, which usually (but not always) face the 
direction of migration. This facilitates the direction of the migration by directing 
transport pathways at the leading edge and is particularly important to achieve persistent 
and efficient migration over long distances (Ma et al., 2001). These studies suggest that 
during epithelial-mesenchimal transition, branching morphogenesis, invasion and 
polarized migration the driving forces for cell motility are derived from the cytoskeletal 
reorganization of actin which is controlled by the members of the Rho GTP-binding 
protein family. These proteins cycle between an inactive (GDP-bound) and an active 
(GTP-bound) state in which they interact with several effector proteins. The conversion 
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from the active to the inactive conformation is regulated by members of the guanine 
nucleotide exchange factors (Cerione and Zheng, 1996) whereas the conversion from the 
active to the inactive state is stimulated by the family of GTPase-activating protein 
(Lamarche et al., 1996). Rho-like GTPase interacts with numerous different downstream 
effector proteins that drive specific cell responses. The molecular cloning of many 
effectors from a variety of different organisms revealed that many of these molecules 
share a common Cdc42-Rho Interacting Binding domain, the CRIB domain (also known 
as GTPase Binding Domain, GBD or PBD). The CRIB domain-containing effectors are 
structurally and functionally diverse and include serine/threonine kinases, tyrosine 
kinases, actin binding proteins and adapter proteins (Pirone et al., 2001). Among these 
effectors, the p21-activated kinase (PAK) family and Rho kinase isoform have been 
implicated as mediators of actin reorganization (Sells et al., 1997) (Leung et al., 1996). 
PAK kinases bind to and are strongly activated by GTP-bound Cdc42 and Rac (Manser et 
al., 1994) (Martin et al., 1995), whereas Rho kinases bind to activated Rho (Leung et al., 
1995) (Ishizaki et al., 1996). It is quite well established that RTK-mediated activation of 
Rho promotes cytoskeleton reorganization (Ridley and Hall, 1992) inducing the 
corresponding change on the actin cytoskeleton. PDGF, EGF and Insulin promote Rac 
activation (Nobes and Hall, 1995). Moreover it has been shown that HGF promotes the 
activation of Cdc42 and Rac (Royal et al., 2000). Furthermore, the stabilization of 
directional movement (chemotaxis) requires input from external cues and this is tightly 
controlled by Cdc42. The best studied example of this event is in macrophages cells 
moving along a chemotactic factor gradient. When Cdc42 is inhibited, the macrophages 
revert to random walk, whereas inhibition of Rac blocks cell movement completely 
(Allen et al., 1998). Since there is a quite broad degree of cross talk between Cdc42, Rac 
and Rho, it seems that Cdc42 is required to direct and/or stabilize active Rac at the front 
of migrating cells. Thus, the precise tuning in space and time of the Rho-like GTPases 
activation by external cues appears to be a key step during branching morphogenesis, 
epithelial-mesenchimal transitions and polarized migration.
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RESULTS 
 
MLP29, C2C12 and Trophoblast stem cells activate Map kinase, Akt and Gab1 
upon HGF stimulation 
 
In order to choose a suitable cell line for the identification of HGF-target genes, 
we first investigated, in three different cell lines (MLP29, C2C12 and Trophoblast Stem 
cells), the time-course and strength of activation/phosphorylation of three signal 
transducers known to be important for the Met receptor mediated biological functions: 
p44 Map kinase, PI3 kinase and the multi-adaptor protein Gab1 (Fig.10-11). 
MLP29 is a  liver-derived cell line which expresses physiological levels of Met 
receptor (Brand-Saberi et al., 1996; Medico et al., 1996), C2C12 is a myoblast cell line 
known to express Met receptor (Bladt et al., 1995) (Brand-Saberi et al., 1996; (Tatsumi et 
al., 1998), and the Trophoblast Stem cells (TS cells) are primary cell in which HGF/Met 
biological functions had not yet been characterized.  
MLP29, C2C12 and TS cells were stimulated with 40ng/ml of HGF and harvested 
over a time course. The total protein lysate was subjected either to a direct western blot 
analysis (Fig.10) or to an immuno-precipitation using a GAB1 specific antibody followed 
by western blot analysis (Fig.11). 
20µg of the total lysate for each experimental condition were directly analyzed by 
western blotting using either anti-phospho-Map kinase, anti-phospho-Akt or anti-tubulin 
specific antibodies. At 5’ after HGF stimulation Map kinase and Akt were found to be 
strongly phosphorylated in all three cell lines and the activation was found to be sustained 
up to 4 hours after HGF stimulation in the case of MLP29 and TS cells (Fig.10 A, C). 
The kinetics of Map kinase and Akt phosphorylation in the C2C12 cell line was 
more transient, returning to basal phosphorylation levels after 1 hour of HGF stimulation 
(Fig.10B). 
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Figure 10. MLP29, C2C12 and 
Trophoblast stem cells activate 
Map kinase and Akt upon HGF 
stimulation. 
(A-C) 20µg of total lysate of 
MLP29 (A) C2C12 (B) and TS 
cells (C) stimulated over a time 
course with 40ng HGF and 
analyzed by direct western 
blotting using anti-phospho-Akt 
(α-P-Akt) anti-phospho-Map 
kinase (α-P-MAPK) or anti-
tubulin (α-Tub) specific 
antibodies. The activation of Akt 
and Map kinase in response to 
HGF is comparable in all three 
cell lines.  
 
 
 
 
 
 
 
 
The western blot analysis with α-tubulin antibody demonstrated equal signal 
intensity in all samples, indicating that total proteins level loaded in each lane was 
comparable. In order to analyze the kinetics of phosphorylation of the multi-adaptor 
protein Gab1, 1mg of total protein extracted at different time points upon HGF 
stimulation from MLP29 and C2C12 was immuno-precipitated using the anti-GAB1 
specific antibody. 
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Figure 11. Phosphorylation 
kinetics of the multi-adaptor 
protein Gab1. 
MLP29 (A) and C2C12 (B) 
were stimulated with 40ng/ml 
of HGF for different time 
points. 1mg of total protein 
was immuno-precipitated using 
an α-GAB1 specific antibody. 
The amount of tyrosine 
phosphorylated GAB1 was 
detected by immuno-blot 
analysis using the α-phospho-
tyrosine specific antibody (α-
P-Y). The α-phospho-tyrosine specific antibody was stripped-off the membrane that was then 
reprobed using an α-GAB1 specific antibody (α-GAB1) showing that an equal amount of total 
GAB1 protein was immuno-precipitated in each sample. 
 
 
The amount of tyrosine phosphorylated GAB1 was detected by immuno-blot 
analysis using an anti-phospho-tyrosine specific antibody (Fig.11A-B). Upon HGF 
stimulation, the multi-adaptor protein GAB1 followed phosphorylation kinetics similar to 
that observed, in the same cell line, for the activation of Map kinase and Akt. In MLP29 
and C2C12 cells, GAB1 was found tyrosine phosphorylatad upon 5 min of HGF 
stimulation. The phosphorylation was sustained for up to 1 hour before returning to basal 
phosphorylation state. In order to confirm that an equal amount of GAB1 protein was 
immuno-precipitated in each sample, the anti-phosphotyrosine specific antibody was 
stripped-off and the membrane reprobed using an α-GAB1 specific antibody. 
The strong and sustained Map kinase, PI3 kinase and Gab1 phosphorylation 
occurring upon HGF stimulation, demonstrated that MLP29, C2C12 and TS cells 
responded to HGF in activating at comparable levels three of the most important 
signaling pathways downstream of the Met receptor. 
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MLP29 proliferate and scatter upon HGF stimulation 
 
The ability of HGF to induce biological responses in MLP29 was verified using a 
BrdU incorporation assay (Fig.12). MLP29 cells were starved in 0.1% Fetal Bovine 
Serum (FBS) containing media for 96 hours. The cells were then stimulated with HGF 
for 6 hours and Bromodeoxyuridine (BrdU) was added for another 2 hours. The cells 
were then fixed and immuno-stained using the α-BrdU specific antibody. Figure 3 shows 
a significant increase in BrdU incorporation confirming that HGF induces S phase entry 
of MLP29 cells. Furthermore, the ability of HGF to induce scattering of MLP29 was 
confirmed. 
 
 
Figure 12. MLP29 
proliferate upon 
HGF stimulation 
MLP29 cells were 
starved in 0.1% FBS 
containing media for 
96 hours. The cells 
were then either left 
in starving media (starved) or stimulated with 40ng/ml of  HGF for 6 hours (+HGF). The cells 
were incubated for 2 hours with a Uridine homologue, BrdU, which is incorporated by the DNA 
polymerase into the newly synthesized DNA. Cells were then fixed and immuno-stained using the 
α-BrdU specific antibody thus labeling proliferating cells (Red staining). 
 
Microarray analysis of HGF-stimulated MLP29 cells 
 
Part of the efforts to understand molecular events downstream of HGF/Met 
signaling has been to examine the expression of genes regulated by Met signaling.  
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To analyze global gene expression in HGF-stimulated MLP29 cells a high density 
cDNA microarray was produced in collaboration with Dr. Tomoko Iwata and Luca Dolce 
at the European Molecular Biology Laboratory-EMBL (Heidelberg) core facility 
(Wilhelm Ansorge’s group) using the National Institute of Aging (NIA) 15,247 clone set 
(Tanaka et al., 2000). Briefly, the library was amplified by polymerase chain reaction 
(PCR) using two universal oligonucleotides (Cortes-Canteli et al., 2004). The size and 
quality of the PCR amplified products were then controlled by Agarose gel 
electrophoresis (Fig.13).  
 
Figure 13. Agar gel 
electrophoresis analysis of 
PCR-amplified NIA 
library clones. 
The NIA 15,247 clone set 
(Tanaka et al., 2000) was 
amplified by PCR using two 
universal oligonucleotides 
(Cortes-Canteli et al., 2004). 
The amplified PCR products 
were purified and analyzed 
by Agarose gel 
electrophoresis in order to 
control their size and 
quality. The figure shows 
Agar gel electrophoresis 
analysis of 192 PCR- amplified products. The PCR-amplified clones’ size (black bands) was 
ranging between 500 and 2000 base pairs.  
 
 
The PCR products were further purified and spotted at high density on glass 
coverslips. The cDNA probes derived from untreated or 4 hours HGF stimulated MLP29 
cells were fluorescently labeled with Cy3-dUTP (green) or Cy5-dUTP (red), respectively. 
These probes were applied simultaneously onto the microarray, and the two fluorescent 
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images were scanned with a fluorescence laser-scanning device (Fig.14 A, C). Green and 
red fluorescent signals indicated genes whose expression levels were relatively higher in 
cells untreated or HGF-stimulated, respectively. The differential expression of each gene 
was calculated from the relative intensity of the Cy5 versus Cy3 fluorescent signal 
(Fig.14B,D). Two independent experiments were conducted comparing untreated and 4 
hours HGF stimulated MLP29 cells and one experiment was conducted comparing two 4 
hours HGF-stimulated samples (background control). Figure 14 B shows one 
representative plot of the differential expression of the 15,247 genes in one of the two 
experiments conducted comparing untreated and 4 hours HGF stimulated cells, while 
figure 14 D represents the plot of the control experiment carried-out comparing 4 hours 
HGF-stimulated samples.  
As expected overall, the expression of most genes was not affected by HGF 
stimulation. Notably, most of the genes were differentially regulated comparing untreated 
versus 4 hours HGF stimulated samples (Fig.14B). Very few genes were found to be 
differentially regulated in the plot representing the control experiment (Fig. 14D). 
Our criteria for the selection of differentially expressed genes were as follows: 
first, Sum of Median (SOM) value (intensity of the Cy5 and Cy3 signals) higher than 
5000. Second, average of the fold of induction/repression (relative intensity of the Cy5 
versus Cy3) higher than 1.8 fold change in two independent experiments. Third, absence 
from background control experiment.  
Using these criteria a total of 79 genes in HGF stimulated cells had a differential 
expression value in all the experiments compared with untreated cells and were therefore 
considered to be regulated by HGF stimulation. 
Among the 79 genes, we identified 59 genes that were up-regulated in cells 
stimulated with HGF in comparison to untreated cells, as well as 20 genes that were 
down-regulated. Roughly half of the identified genes (36 genes) currently do not show 
any homology to genes with annotation or known function upon blast searches against 
nucleic acid gene database. The group of HGF regulated genes was further categorized 
using the information provided by the NIA mouse 15k cDNA clone gene ID list initially 
and further modified when necessary (Table 1).  
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Figure 14. 
Microarray 
analysis of HGF-
stimulated MLP29 
cells. 
cDNA probes 
derived from 
untreated or 4 
hours HGF 
stimulated MLP29 
cells were 
fluorescently 
labeled with Cy3-
dUTP (green) or 
Cy5-dUTP (red), 
respectively. These 
probes were applied 
simultaneously onto the microarray, and the two fluorescent images were scanned with a 
fluorescence laser-scanning device. (A and C) Representative area of the micro array comparing 
untreated and 4 hours HGF stimulated MLP29 cells (A, 4h HGF/untreated) and probes deriving 
only from 4 hours HGF-stimulated samples (background control, C, 4h HGF/4h HGF). The 
differential expression of each gene was calculated from the relative intensity of the Cy5 versus 
Cy3 fluorescent signal (Intensity Cy3/Cy5)  Green and red fluorescent signals indicated genes 
whose expression levels were relatively higher in cells untreated or HGF-stimulated, 
respectively. (B,D) Representative plot of the differential gene expression comparing either 
untreated and 4 hours HGF stimulated cells (B) or two 4 hours HGF stimulated probes (D). Note 
that overall, the expression of most genes was not affected by HGF stimulation (Intensity 
Cy3/Cy5 of most of the gene =1) and that very few genes were found to be differentially regulated 
in the control experiment (D). Every dot in the plot corresponds to 1 gene spotted on the 
microarray. Only genes with more than 5,000 of the value of sum of median (S.O.M.) and with an 
average fold induction (Intensity Cy3/Cy5) of more than 1.8 fold were selected.  
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Table 1. HGF Transcripts regulated by HGF in MLP29 cells 
The tables summarize genes whose expression levels changed significantly upon HGF treatment 
in comparison to mock-treated cells. Average fold induction was calculated from duplicate 
hybridizations and genes that showed more than ±1.8 fold changes were included. Functional 
categorization, GDB accession number, and Unigene ID, are based on the information given in 
the NIA mouse 15k cDNA clone gene ID list. Gene names indicated in red ink were validated by 
northern blot analysis (see figure 14 and 16). 
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These genes can be clustered into several groups, as genes involved in apoptosis 
response, cell cycle regulation and progression, energy and metabolism, stress responses, 
extracellular matrix protein and cellular-structural protein, translational control, signal 
transduction and transcriptional control. Some of these cDNA sequences also correspond 
to expressed sequence tags for which the full-length sequence is not available in public 
domain data bases and to unknown genes.  
These data showed that the microarray system was able to identify known and 
unknown HGF/Met transcriptionally regulated genes. 
 
Microarray data validation by northern blot analysis 
 
To verify the results of the microarray experiments, northern blot analysis on 
RNA samples isolated from untreated and 4 hours HGF-stimulated MLP29 cells was 
performed. Twenty µg of total RNA was extracted either from MLP29 in the growing 
phase or from 4 hours HGF stimulated. The total RNA was then electroporated on 
Agarose gel and immobilized onto nylon membrane. As probes for the northern blot 
analysis, several cDNA encoding genes found to be up or down-regulated by HGF 
stimulation in the microarray list were isolated from the NIA mouse 15k cDNA clone set 
(table1, red lines), radiolabelled and hybridized on the RNA blotted membrane (Fig.15). 
After the removal of the quantified background signal for every sample, the ratio between 
the specific signal in the untreated sample (Fig.15, -) and in the 4 hours HGF stimulated 
sample (Fig.15, +) was calculated and normalized against glyceraldehyde-3-phosphate 
dehydrogenase (G3PDH) signal in order to exclude differences due to the loading of total 
RNA. 
The majority of the selected genes were validated by northern blot analysis. 
However, the fold of induction calculated by northern blot analysis was in average higher 
compared to microarray analysis (compare table1 red lines with Fig.15 MLP29; i.e. 
BG073094, microarray average fold of induction: 3.76; northern blot fold of induction: 
10.9). 
Among the verified genes one was a known HGF/Met transcriptional target (Tissue-type 
plasminogen activator, tPA, BG069863) (Hecht et al., 2004) (Paciucci et al., 1998). Three 
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genes were signal transduction proteins (Ras related protein Rab, BG070182; 
Gene33/MIG6, G063865 and Signal sequence receptor beta, Ssr2, NM_025448), one 
structural protein (γ-actin, CK334526), one metabolic protein (Ornithine decarboxylase, 
BG069647) and two apoptosis related genes (Tumor necrosis factor receptor superfamily 
member 12a and 23, BG064436 and BG 025860).  
 
 
Figure 15. 
Microarray data 
validation by 
northern blot 
analysis 
Northern blot 
analysis on RNA 
isolated from 
untreated (HGF -) 
and 4 hours HGF-
stimulated (HGF 
+) MLP29, C2C12 
and TS cells. 
Several cDNA 
encoding genes 
found to be up or 
down-regulated by 
HGF stimulation 
in the microarray 
list were isolated 
from the NIA 
mouse 15k cDNA clone set and used as probes for the northern blot analysis (see also table 1 and 
2, red lines). The ratio between the specific signal in the untreated sample (HGF -) and in the 4 
hours HGF stimulated sample (HGF +) was calculated (Fold of induction) and normalized 
against the loading control G3PDH signal. 
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The northern blot analysis confirmed and verified most of the genes predicted to 
be up or down-regulated by the micro array analysis. These results demonstrated the 
reliability of the microarray system as a tool for the identification of HGF/Met 
transcriptionally regulated genes. 
Met/HGF transcriptionally regulates the newly identified target genes in cells of 
different origin 
 
Next, we wanted to investigate whether the newly identified HGF/Met target 
genes were broadly regulated by HGF or if they were rather regulated in a cell line-
specific manner. Using the same cDNA probes mentioned above, northern blot analysis 
was performed on RNA extracted from untreated and 4 hours HGF stimulated C2C12 
and primary TS cells. As shown in figure 15, most of the HGF target genes were found to 
be regulated not only in MLP29 but in C2C12 and primary TS cells as well. Notably, 
even if the strength and duration of MAP kinase and Akt activation was comparable in all 
the three cell lines (see Fig.10), the fold of gene induction upon HGF stimulation in TS 
cells was, in average, lower compared to both MLP29 and C2C12. 
These results suggested that most of the HGF/Met trascriptionally regulated genes 
were induced in three cell lines with different origin. Furthermore the data suggested that 
these genes may have a general function in regulating HGF/Met overall biological 
responses. 
 
Few transcripts are specifically regulated by HGF and not by other growth factors 
 
Since most of the genes were regulated by HGF stimulation in a cell line-
independent manner, we next asked whether the transcriptional regulation of some of the 
newly identified genes was HGF specific. To this aim the MLP29 cells were stimulated 
with two other growth factors, namely Fibroblast Growth Factor-2 (FGF2) and Platelet-
Derived Growth Factor (PDGF), and the regulation of target genes compared to the ones 
induced by HGF stimulation.  
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First, the ability of FGF2 and PDGF in comparison with HGF to promote Map 
kinase phosphorylation was assessed by western blot analysis (Fig.16). MLP29 cells were 
stimulated with 40ng/ml of HGF, 30ng/ml of FGF2 or with 30ng/ml of PDGF. 
 
Figure 16. HGF, FGF2 and 
PDGF promote Map 
kinase phosphorylation in 
MLP29 
MLP29 cells were stimulated 
with 40ng/ml of HGF, 
30ng/ml of FGF2 or with 30ng/ml of PDGF. The cells were then harvested at different time 
points and 20µg of the total lysate for each experimental condition were directly analyzed by 
western blotting using either an α-phospho-Map kinase (W.B. α-P-MAPK) or α-Map kinase 
(W.B. a-MAPK) specific antibody that was used as an internal protein loading control. 
 
The cells were then harvested at different time points and 20μg of the total lysate for each 
experimental condition were directly analyzed by western blotting using either an α-
phospho-Map kinase or α-Map kinase specific antibody used as an internal protein 
loading control. 
Even if HGF was found to be the most potent Map kinase activator in MLP29 at 5 
and 10 minutes upon stimulation, FGF2 and PDGF stimulation led to a comparably 
strong increase in Map kinase phosphorylation.  
Once verified that HGF, FGF2 and PDGF were able to activate Map kinase in a 
comparable manner downstream of their respective tyrosine kinase receptors, total RNA 
was extracted from both untreated or 4 hours HGF, FGF2 or PDGF stimulated MLP29 
cells. Twenty µg of the total RNA were then subjected to northern blot analysis using as 
probes some of the HGF target genes (Fig.17). One gene was found to be mainly 
regulated by FGF2 (BC016400), three genes were found to be equally regulated by HGF, 
FGF2 and PDGF (CK334526; BC016400; BG064297), one gene was found to be mainly 
regulated by HGF and FGF2 (BG073094) and one gene was found to be mainly regulated 
by HGF (BG063865). 
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Figure 17. Northern blot analysis of HGF, 
FGF2 or PDGF stimulated MLP29 cells 
MLP29 cells were stimulated with 40ng/ml of 
HGF, 30ng/ml of FGF2 or with 30ng/ml of 
PDGF, total RNA was extracted and analyzed 
by northern blotting. Three genes were found 
to be equally regulated by HGF, FGF2 and 
PDGF (CK334526; BC016400; BG064297), 
one gene was found regulated by HGF and 
FGF2 (BG073094), one gene was found regulated by FGF2 (BC016400) and one gene was found 
regulated by HGF (BG063865). The ratio between the specific signal of the untreated sample (-) 
and the 4 hours stimulated sample (HGF, FGF2 and PDGF) was calculated and normalized 
against the loading control G3PDH signal. 
 
 
MIG6 is specifically up-regulated by HGF stimulation 
 
Among the highly regulated genes, we identified and concentrated further 
experiments on the gene encoding Mig6 adaptor protein (GDB accession number: 
BG063865) as a HGF transcriptionally regulated target gene (Fig.15 and 17). As 
described previously, mig6 expression was induced between 1.4 – and 80-fold by 4 hours 
HGF stimulation depending on cell type and experiment (Fig.15). In contrast, its 
expression was only mildly induced by FGF-2 and PDGF (Fig.17), although both growth 
factors induced robust phosphorylation of Map kinase in MLP29 cells (Fig.16).  
Next, mig6 induction upon HGF stimulation was examined in a more detailed 
northern blot analysis. MLP29 were stimulated with 40ng/ml of HGF for 1, 2, 4 and 6 
hours and the northern blot analysis performed using the mig6 radiolabelled probe 
(Fig.18). The northern blot in figure 18 shows that mig6 mRNA was half maximally 
induced after 1 hour HGF stimulation and the presence of the mRNA was sustained at 
high level for a further 6 hours after HGF stimulation.  
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Figure 18. Northern blot analysis of 
the mig6 transcript induction upon 
HGF stimulation 
MLP29 were stimulated with 40ng/ml of 
HGF for 1, 2, 4 and 6 hours, total RNA 
was extracted and the northern blot 
analysis performed using the Mig6 radiolabelled probe. mig6 mRNA was half maximally induced 
after 1 hour HGF stimulation. G3PDH probe was used as an internal loading control. 
 
 
Furthermore, Mig6 protein was found to be also induced upon HGF stimulation. 
At different time points upon HGF stimulation, total proteins were extracted from 
MLP29 and western blot analysis was performed using the anti-Mig6 specific antiserum 
(Fig.19A). Consistent with the mig6 mRNA induction after HGF stimulation, Mig6 
protein was strongly induced reaching the half maximal level at 1 hour HGF stimulation. 
The western blot analysis in figure 19 A shows a robust and sustained induction up to 8 
hours of HGF stimulation. Moreover we asked whether Mig6 protein was up-regulated in 
a more physiological cell system such as the primary embryonic hepatocytes. Using the 
Mig6 specific antibody, western blot analysis of HGF stimulated primary hepatocytes 
was performed as shown in figure 19 B. Upon HGF stimulation primary hepatocytes 
were found to up-regulate Mig6 protein as well. The Mig6 up-regulation in primary 
culture followed a somehow delayed kinetics compared to MLP29 cells having the half 
maximal induction at around 2 hours from HGF stimulation. Consistent with these data, 
Met receptor tyrosine kinase was found to be co-expressed in the hepatocyte culture 
system. 
This work provides evidence that Mig6 is a newly identified HGF-target gene, its 
mRNA and protein up-regulation was shown to be half maximal at 1 hour HGF 
stimulation. Furthermore, HGF-mediated Mig6 up-regulation was found reproducible in a 
more physiological system such as a primary embryonic hepatocytes culture. 
Furthermore Mig6 and Met receptor tyrosine kinase were demonstrated to be co-
expressed in hepatocytes.  
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Figure 19 Western blot analysis 
using Mig6 specific antibody of 
HGF-stimulated MLP29 and 
primary hepatocytes  
(A) At different time points upon 
stimulation with 40ng/ml of HGF, total 
proteins were extracted from MLP29 
and western blot analysis was 
performed using the anti-Mig6 specific 
antiserum (W.B. α-Mig6). Mig6 
protein was strongly induced by HGF, 
reaching the half maximal level at 1 
hour of stimulation. (B) Primary 
hepatocytes were stimulated with 40ng/ml of HGF for 1, 2 and 4 hours, total proteins were 
extracted and analyzed by western blotting using the anti-Mig6 (W.B. α-Mig6), anti-Met (W.B.α-
Met) and anti-tubulin (W.B. α-Tub) specific antibody. The half maximal induction was found to 
be at around 2 hours from HGF stimulation. Consistently Met protein was found to be co-
expressed in the same cell culture. The wetern blot anti-tubulin (W.B. α-tub, A and B) shows that 
every sample contained an equal amount of total protein. 
 
mig6 and met receptor tyrosine kinase transcripts are co-expressed in-vivo 
 
Next the co-expression of mig6 and met transcripts in embryonic tissues was 
analyzed. By in situ hybridization analysis both transcripts were found to be partially co-
expressed in the embryonic somitic mesoderm at embryonic day 9.5 (E9.5) (Fig.20A, B). 
mig6 staining was positive in developing somites (Fig.20A) whereas only the more 
ventral tip of the somites was positive for met expression (Fig.20B). The artificial overlay 
in figure 20 C shows that mig6 and met transcripts were found to be partially co-
expressed in the same somitic structure at E9.5. Coronal sections of the whole mount in-
situ hybridizations (Fig.20D-G) confirmed the mig6 positive hybridization signal 
throughout the somitic structure. Furthermore met and mig6 transcripts were found 
partially co-localized at the ventral tip of the somites. 
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Figure 20. mig6 and met 
receptor tyrosine kinase 
transcripts are co-expressed in-
vivo 
In situ hybridization analysis 
using mig6 (A, D, E) and met (B, 
F, G) mRNA antisense-probes in 
the whole embryo at E9.5. Both 
transcripts were found to be co-
expressed in the embryonic 
somitic mesoderm. The possible 
co-localization of the two 
transcripts was especially evident 
at the limb level somites (A-C, 
somites VI, VII and VIII). mig6 
specific staining was positive in all the forming somites (A) whereas the ventral tip of the limb 
somites was positive for met expression (B). (C) Artificial overlay of the mig6 and met signals. 
mig6 and met transcripts are partially co-expressed in the same somitic structure. (D-G) Coronal 
sections of the whole mount in-situ hybridizations. mig6 positive hybridization signal extend 
throughout the somitic structure (arrow) whereas met positive signal is more evident at the 
ventral tip of the somites. N.T. neural tube. 
 
 
Later during development, at embryonic day 13.5, the degree of co-expression of 
mig6 and met transcripts was higher. Both transcripts were found in the alveoli of 
embryonic lung, in liver parenchyma (Fig.21B and C), and in intercostal and body wall 
muscles of wild-type embryos (Figure 21F and G). The mig6 mRNA sense probe was 
used as negative control (Fig.21A and E) confirming the specificity of mig6 in-situ 
staining.   
We next asked if the Met receptor was able to regulate mig6 transcript in vivo by 
the use of embryos expressing a signaling deficient Met receptor: metd/d (Maina et al., 
1996; Maina et al., 2001). Reduced levels of mig6 mRNA in the lung and liver of E13.5 
metd/d embryos were found (Figure 21D). 
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Figure 21. mig6 and met in-situ hybridization at E13.5 
At E13.5 mig6 and met receptor transcripts were found to be more broadly co-expressed. (B,C) 
Both transcripts were found in the alveoli of embryonic lung (Lu), in liver parenchyma (Li) , and 
in intercostal (i.m.) and body wall (b.w.) muscles of wild-type embryos (B-C; F-G). The sense 
probe was used as a negative control of the staining (A,E). (D) Reduced level of mig6 mRNA was 
found in the lung and liver parenchyma of the metd/d embryos. R.i. ribs. Dotted line in A-D: 
diaphragm. 
 
 
Furthermore using the Mig6 specific antiserum, expression of Mig6 protein was 
confirmed in structures positive for mig6 mRNA, including intercostal and body wall 
muscles (Fig.22A-B),. In order to verify further the specificity of the Mig6 immuno-
staining, the antibody was pre-incubated with recombinant purified Mig6-GST fusion 
protein. As expected, pre-incubation of the Mig6 specific antiserum with GST alone did 
not have any effect on the immuno-staining signal (compare Fig.22A and B). On the 
other hand, pre-incubation of the Mig6 specific anti-serum with the recombinant purified 
Mig6 antigen strongly reduced the intensity of the immuno-staining signal (Fig.22C). 
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Figure 22. Anti-Mig6 
immunostaining 
Expression of Mig6 protein was 
detected in structures positive for 
mig6 mRNA, including intercostal 
(i.m.) and body wall muscles (b.w.). (B) Pre-incubation of the Mig6 specific antiserum with GST 
alone (GST) did not have any effect on the signal of the immuno-staining, whereas the pre-
incubation of the Mig6 specific anti-serum with the recombinant purified Mig6 antigen (C, +Ag) 
strongly reduced the intensity of the immuno-staining signal. 
 
 
Taken together the data suggested that mig6 expression was developmentally 
regulated. mig6 transcripts were found in developing somites at embryonic day 9.5 where 
they partially co-localized with met. Moreover mig6 and met were found to co-localize at 
embryonic day 13.5 in the liver parenchyma, in lung alveoli, and in skeletal muscles. The 
results obtained using Met loss of function mice provided evidence that Met regulates 
mig6 transcripts in vivo. 
 
Mig6 overexpression inhibits HGF-dependent MLP29 cell migration 
 
The only cellular context in which Mig6 had previously been implicated was cell 
division (Anastasi et al., 2003; Fiorentino et al., 2000; Hackel et al., 2001; Xu et al., 
2004). Since HGF/Met signaling is, however, critical for myoblast migration, the effect 
of Mig6 overexpression on HGF/Met-mediated cell was tested. In order to explore this 
function of Mig6, the full length protein was tagged using the V5 epitope (Mig6FL-V5) and 
overexpressed in MLP29. We first verify by immuno-cytochemistry analysis that the 
fusion protein was overexpressed in MLP29 cells and that it was recognized by both the 
anti-Mig6 and the anti-V5 specific antibody. MLP29 cells were transfected with a control 
plasmid encoding the LacZV5 fusion protein (Fig.23A-C) or with the Mig6FL-V5 encoding 
plasmid (Fig.23D-F). As shown in figure 23A, the Mig6 immuno-staining did not show 
any Mig6 overexpressing cells upon transfection of the control LacZV5 plasmid, whereas 
cells expressing high level of the LacZV5 protein were immuno-stained using a V5 
Results 
54 
specific antibody (Fig.23B, C). On the other hand the transfection of the Mig6FL-V5 
construct led to the overexpression of Mig6 protein (Fig.23D) that was recognized by 
immuno-fluorescence using both the V5 and the Mig6 specific antibody (Fig.23E, F). 
 
 
Figure23. Mig6FL-V5 fusion protein 
detection by immuno-fluorescence  
MLP29 cells were transfected with a 
control plasmid encoding the 
LacZV5 fusion protein (A-C) or with 
the Mig6FL-V5 encoding plasmid (D-
F). The transfected cells were 
immuno-stained using both the anti-Mig6 (A,D, red channel) and the anti-V5 (B,E, green 
channel) specific antibody. The overexpressed Mig6FL-V5 protein is recognized by both the 
specific antibody (C,F, yellow signal). 
 
Once verified that the Mig6FL-V5 construct was able to overexpress the tag version 
of the Mig6 protein we analyzed the effects of Mig6 on HGF/Met-mediated cell 
migration in the Boyden chamber migration assay. This assay is composed of a porous 
membrane that separates an upper and lower compartment. Oval cells were either 
transfected with a plasmid encoding yellow fluorescent protein (YFP) or co-transfected 
with plasmids encoding full-length Mig6FL-V5 and YFP in a ratio of 5:1. For each 
experimental condition equal numbers of cells were either seeded onto coverslips for 
immunocytochemical analysis or onto the upper compartment of the membrane and 
exposed to 40ng/ml of HGF or 10% fetal bovine serum (FBS) in the lower compartment. 
We verified first that the YFP-positive cells were overexpressing the Mig6FL-V5 fusion 
protein by immuno-cytochemistry analysis. As shown in figure 24 A-C all YFP positive 
cells were overexpressing Mig6 protein. It has to be noted that since the Mig6FL-V5 
encoding plasmid was transfected in a five times excess in respect to the YFP plasmid, 
several cells were found to express the Mig6 recombinant protein being negative for YFP 
expression. The transfection efficiency was calculated to be around 70%. 
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Figure 24. YFP-positive cells overexpress the Mig6FL-V5 fusion protein. 
MLP29 were co-transfected with plasmids encoding full-length Mig6FL-V5 and YFP in a ratio of 
5:1. The merge (C) of the YFP signal (A) and the Mig6 specific immuno-fluorescence signal (B) 
shows that all the YFP-positive cells co-express Mig6FL-V5 (B) fusion protein. 
 
Cell migration through the membrane into the lower compartment was stimulated 
by HGF in a dose-dependent manner (See Fig.28 E and 29). At 40ng/ml HGF, the 
migration of transfected YFP-positive cells was enhanced between 30 to 40-fold over 
unstimulated cells (Fig.25E). Figure 25 A-D shows representative images of 
YFP/Hoechst dye-labeled cells which migrated into the lower compartment of the 
Boyden chamber. The presence of Mig6 reduced HGF-stimulated cell migration approx. 
3-fold (Fig.25E, p<0.001, t-test). In contrast, cell migration stimulated with 10% FBS 
was unaffected by Mig6 overexpression (p=0.121, t-test). 
Since Mig6 overexpression reduced cell proliferation under a variety of 
conditions (Fiorentino et al., 2000; Hackel et al., 2001) we asked whether the effect on 
cell migration could be secondary to reduced cell proliferation. Transfected cells were 
therefore exposed to 1.6 μg/ml of the DNA polymerase inhibitor aphidicolin (Ikegami et 
al., 1978) 24h prior to plating onto the membrane and the assay was further conducted in 
the presence aphidicolin. In order to verify that the Aphidicolin treatment was efficiently 
able to block proliferation we performed a BrdU incorporation assay. The assay consists 
of incubating cells with a Uridine homologous, BrdU, which is incorporated by DNA 
polymerase into newly synthesized DNA. The BrdU is then detected by the use of an 
anti-BrdU specific antibody, therefore identifying the cells that are actively synthesizing 
DNA. 
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Figure 25. Mig6 overexpression inhibits 
HGF-mediated migration. 
Oval cells were either transfected with a 
plasmid encoding Yellow Fluorescent 
Protein (YFP) or co-transfected with 
plasmids encoding full-length Mig6-V5 and 
YFP in a ratio of 5:1 (YFP/Mig6FL-V5). (A-
D) Representative images of YFP 
positive/Hoechst dye-labeled cells which 
migrated into the lower compartment of the 
Boyden chamber in response to either 
serum (10% FBS) or 40ng HGF. (E) 
Quantification under different experimental 
conditions of cell migration expressed as 
fold of induction over unstimulated cells. 
Mig6 overexpression reduced HGF-
stimulated cell migration approx. 4-fold (p<0.001, t-test). In contrast Mig6 overexpression was 
unaffecting serum-stimulated cell migration (p=0.121, t-test). 
 
 MLP29 cells were plated onto coverslips and stimulated over-night with 40ng/ml 
of HGF. The cells were then incubated for 2 hours with 10µM of BrdU and immuno-
stained using an anti-BrdU specific antibody. The percent of BrdU positive cells 
(proliferating) over negative (quiescent) was then scored. Typically, Aphidicolin 
treatment reduced the incorporation of BrdU into MLP29 cells 6 to 15-fold (data not 
shown). Under these conditions, HGF-stimulated cell migration was also significantly 
reduced by Mig6 overexpression indicating that Mig6 had a direct influence on Met-
mediated cell migration independently of its effect on cell proliferation (Fig. 26, p<0.01, 
t-test).  
Together these data indicate that Mig6 overexpression is sufficient to inhibit 
HGF-dependent migration in MLP29 cells. Furthermore this effect was found to be 
specifically downstream of HGF/Met. The overexpression of Mig6, in fact, is not 
sufficient to inhibit serum-dependent MLP29 cell migration, suggesting that the cells 
maintain the potentiality to migrate in the presence of high amount of exogenous Mig6 
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protein. Moreover the inhibition of HGF-dependent migration via Mig6 was not found to 
be a secondary effect of the known Mig6 anti-mitogenic effect, since the same result was 
obtained in the presence of the mitogenic inhibitor Aphidicolin.   
 
 
Figure26. Mig6 inhibits cell 
migration independently of 
cell proliferation 
Transfected cells were 
exposed to 1.6 μg/ml of the 
DNA polymerase inhibitor 
Aphidicolin 24h prior to 
plating onto the membrane. 
The migration assay was 
conducted in the presence of 
Aphidicolin. Mig6 
overexpression (grey bars) inhibited HGF-, but not serum-, mediated migration of about 3-times 
compared to controls (black bars) also in the presence of the proliferation inhibitor Aphidicolin 
(p<0.001, t-test).  
 
 
Mig6 is a physiological suppressor of Met-mediated cell migration 
 
We next investigated whether endogenous Mig6 suppressed HGF/Met-mediated 
cell migration by knocking down Mig6 protein levels using RNA interference (Elbashir 
et al., 2001a; Elbashir et al., 2001b). MLP29 cells were transfected with either siRNAs 
specific for green fluorescent protein (GFP) or mig6 and the levels of Mig6 protein 
analyzed by immunostaining and immunoblotting. mig6 siRNA, but not control GFP 
siRNA, specifically knocked down Mig6 immunoreactivity 96 hours after transfection 
(Fig.27A,B). mig6 siRNA suppressed HGF-stimulated induction of Mig6 (Fig.27C, 
compare 4h time point +/- mig6 siRNA). The knock down was specific for Mig6, since 
endogenous alpha-tubulin and Met levels were unaffected (Fig.27C and data not shown). 
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Figure 27. mig6 siRNA 
efficiently knock down 
Mig6 protein  
(A,B) MLP29 cells were 
transfected with either 
GFP specific siRNAs (A) 
or with mig6 specific 
siRNAs (B) for 4 days, then 
fixed and Mig6 protein 
levels detected using the 
Mig6 specific antibody. (B) 
Cells were visualized using 
Hoechst dye. Note the 
efficient knock-down of 
Mig6 protein level upon transfection of mig6 siRNAs. (C) Western Blot analysis of MLP29 
transfected with control GFP siRNAs (-) or mig6 specific siRNAs (+) for 4 days. After 
transfection the cells were stimulated with 40 ng/ml of recombinant HGF for the indicated times 
and cell lysates analyzed using SDS-PAGE and immunoblotting using α-Mig6 or α-tubulin 
specific antibodies. Note the specific reduction of Mig6 levels most clearly seen at the 4h time 
point. 
  
 
To investigate Mig6’s loss of function role in cell migration, controls and mig6 
siRNA transfected cells were harvested and seeded onto the membrane (upper 
compartment) of the Boyden chamber. Cells were allowed to attach to the membrane and 
different concentrations of HGF were added to the lower chamber for 16 hours. Figure 28 
A-D shows representative images of cells which migrated into the lower compartment. 
Quantification of the cells revealed that under optimal HGF concentrations condition, 
knock down of Mig6 enhanced cell migration three-fold (Fig.28E). Because the 
transfection efficiency was certainly less than 100% and yet all cells were counted, the 
effect of the Mig6 knock down may be underestimated. Similar results were obtained 
with a separate set of siRNA oligonucleotides (Fig.29). These findings demonstrated that 
Mig6 is required in order to suppress HGF/Met-mediated cell migration of MLP29. 
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Figure 28. Endogenous Mig6 inhibits 
HGF-induced cell migration in MLP29. 
(A-D) Representative fields of Hoechst dye-
labeled GFP siRNA- and mig6 siRNA-
transfected MLP29 cells that have migrated 
into the lower compartment of the Boyden 
chamber in the presence (+ HGF 40ng/ml) 
or absence of HGF (-HGF). MLP29 cells 
were transfected with either GFP specific 
siRNAs (A,C) or with mig6 specific siRNAs 
(B,D) for 4 days, then transfected a second 
time for 24h, harvested and plated into the 
upper compartment of the Boyden chamber 
and allowed to attach on the membrane. 
HGF was then added to the media of the 
lower compartment of the Boyden chamber 
and the cells were allowed to migrate for 
16h. (E) Quantification of MLP29 migration expressed as fold of induction over unstimulated 
cells. Increasing concentrations of HGF were added to the lower Boyden chamber after 
transfection of either control GFP siRNAs (black bars) or Mig6 siRNAs (gray bars). 5 ng/ml 
HGF, p=0.02; 10ng/ml HGF, p<0.0002; 40ng/ml HGF, p<0.01, t-test. 
 
Figure 29. A second independent set of siRNA oligos 
confirm that endogenous Mig6 inhibits HGF-
mediated cell migration  
MLP29 cells were transfected with either GFP specific 
siRNAs (A,C) or with a second set of mig6 specific 
siRNAs for 4 days, then transfected a second time for 
24h, harvested and plated into the upper compartment of 
the Boyden chamber and allowed to attach on the membrane. The graph shows the quantification 
of MLP29 migration expressed as fold of induction over unstimulated cells. Increasing 
concentrations of HGF were added to the lower Boyden chamber after transfection of either 
control GFP siRNAs (black bars) or the second set of mig6 siRNAs (gray bars) 5 ng/ml HGF, 
p=0.08; 10ng/ml HGF, p<0.009; 40ng/ml HGF, p<0.01, t-test. 
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Endogenous Mig6 inhibits HGF-mediated cell migration independently of cell 
proliferation 
 
Mig6 was found to suppress proliferation upon overexpression of the recombinant 
protein (Fiorentino et al., 2000). Consistent with these data, Mig6 was also found to 
enhance cell proliferation upon endogenous protein knock-down by specific antibody 
microinjection (Fiorini et al., 2002). Accordingly with these observations knock-down of 
mig6 by siRNA also enhanced cell proliferation in MLP29 (Fig 30).  
In order to separate HGF and Mig6 effects on cell migration from cell proliferation, we 
assayed cell migration in the presence of the cell cycle inhibitor Aphidicolin. MLP29 
cells were transfected with control or mig6 siRNA specific oligos for 96 hours. The last 
24 hours the cells were exposed either to a DiMethyl SulfOxide (DMSO) control media 
or to a media containing 1.6µg/ml Aphidicolin. Cells were then harvested, seeded either 
onto coverslips, for testing the proliferation rate in the different experimental condition, 
or onto the upper compartment of the Boyden chamber.  
 
Figure 30. The knock-down of Mig6 by 
siRNA enhanced cell proliferation in 
MLP29 
MLP29 cells were transfected with control 
(black bars) or mig6 siRNA specific oligos 
(gray bars) for 96 hours. The last 24 hours 
the cells were exposed either to a DMSO control media or to 1.6µg/ml Aphidicolin. Cells were 
then harvested, seeded either onto coverslips and incubated with BrdU together with (HGF +) or 
without (HGF -) 40 ng/ml of HGF for 3 hours. The BrdU was then visualized with a α-BrdU 
specific antibody. The proliferation rate under different experimental conditions was calculated 
counting the percent of BrdU positive over the total Hoechst dye-positive cells.  
 
After the cells attached to the membrane, 40ng/ml of HGF was added to the lower 
compartment of the Boyden chamber. The experiments were conducted in the presence of 
either 1.6µg/ml of Aphidicolin or DMSO control media. 
Consistently with previous observations, HGF stimulation and the knock-down of 
Mig6 protein by siRNA (Fig.30, gray bars) led to an increase in BrdU incorporating cells 
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compared to control conditions (Fig.30, black bars). Interestingly upon HGF stimulation, 
the knock down of Mig6 protein by siRNA significantly increased BrdU incorporating 
cells in respect to the control (Fig.30, compare black bars and grey bars). Incubating the 
cells for 24 hours with Aphidicolin resulted in a significant decrease in cell proliferation 
under different conditions (not shown). 
Figure 31A-D shows representative images of Hoechst labeled cells that have 
migrated in response of HGF to the lower side of the filter under different experimental 
conditions. The knock-down of Mig6 protein by siRNA (Fig.31B,D) resulted in a 
significant increase of HGF-induced migration in respect to the control in the absence 
(Fig.31A,B) and in the presence of Aphidicolin (Fig.31C,D). Interestingly the 
Aphidicolin treatment resulted in an overall decrease in the number of migrating cell into 
the lower side of the membrane (compare Fig.31E, GFP siRNA Aphidicolin- and GFP 
siRNA Aphidicolin+). Since the same number of cells were plated onto the membrane, 
this difference is likely to represent the effect on proliferation of HGF and Mig6 during 
the migration assay. 
 
Figure 31. Endogenous Mig6 inhibits HGF-
stimulated migration independently of cell 
proliferation 
Representative Hoechst dye-labeled MLP29 
transfected with either GFP siRNA specific oligos 
(A,C) or with mig6 siRNA specific oligos (B,D) that 
have migrated into the lower Boyden chamber in 
response of HGF. The cells were transfected with 
siRNA for 4 days, then transfected a second time for 
24h, harvested and plated into the upper compartment 
of the Boyden chamber and allowed to attach on the 
membrane. During the last 24 hours cells were 
exposed to either DMSO (A,B) or to 1.6 µg/ml 
Aphidicolin (C,D). (E) Quantification of MLP29 cell 
migration expressed as fold of induction over unstimulated cells. Migration was enhanced in cells 
transfected with Mig6 siRNA (grey bars) compared to GFP siRNA (black bars) in the absence or 
the presence of Aphidicolin (p=0.019 and p<0.002 respectively, t-test). 
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Figure 32. E15.5 
cortical neurons 
over-express the 
Mig6-V5 construct 
Cortical neurons were 
dissected from E15.5 
mouse embryos and 
electroporated with 
expression plasmids 
encoding either GFP (A) or V5-epitope tagged Mig6FL (Mig6FL-V5; B-G). Electroporated cells 
were plated for either 24 hours (A) or 3 days (B,C) onto coverslips for immunocytochemical 
analysis. (A) GFP fluorescent cells (green) among untransfected Hoechst dye-labeled cells. 
Transfection efficiency was generally 40-70%. (B,C) After transfection with Mig6FL-V5, cells were 
cultured for 3 days and immunostained with anti-MAP2 (B) or anti-Mig6 antibodies (C). Note 
that Mig6 did not affect neuronal differentiation. (D-G) Cells were fixed and doubly labeled using 
α-V5 (D) and α-Mig6 (E) antibodies. Note that nearly all V5-labeled cells also express Mig6. 
Similar results were obtained with a HIS-epitope tagged Mig6 expression plasmid (data not 
shown). 
 
Overexpression of Mig6 suppresses HGF/Met-mediated cortical neuron migration 
 
Having established a critical role for Mig6 in HGF/Met-mediated migration of 
MLP29 cells, we next asked whether the functions of Mig6 were specific to cells of 
hepatic origin, or whether Mig6 had a more general role in controlling cell migration 
across different cell lineages. The HGF/Met system has previously been implicated in the 
migration of embryonic cortical interneurons from the ventral to the dorsal telencephalon 
(Powell et al., 2001). Consistent with a potential role as modulator of Met signaling, mig6 
mRNA was found co-expressed with met in the cortical plate of E15.5 cortex, albeit at 
low levels (not shown). 
To overexpress Mig6 in embryonic cortical neurons, we used two different tagged 
version of Mig6: a His-epitope-tagged (Mig6FL-His) and a V5-epitope-tagged (Mig6FL-V5). 
Cortical neurons were dissected out from E15.5 embryo cortex and electroporated with 
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different constructs. We first addressed the efficiency of electroporation of primary 
neurons by transfecting a control plasmid encoding the Yellow Fluorescent Protein 
(YFP). Around 40 to 70 percent of the Hoechst stained neurons were identified to be YFP 
positives (Fig.32A) indicating a high transfection efficiency. 
Mig6 overexpression did not affect differentiation of cortical neurons as judged 
by microtubule-associate protein 2 (MAP2) expression, nor survival (figure 32B,C and 
data not shown) 
Mig6FL-V5plasmid was then electroporated and the expression of the recombinant 
protein verified by immuno-cytochemistry using the combination of the α-Mig6 and the 
α-V5 specific antibody (Fig.32D-G). Nearly all cortical neurons were found positive for 
both Mig6 (Fig.32E-G) and V5 expression (Fig.32D,F,G). 
After having verified the overexpression of the recombinant Mig6FL-V5 protein, 
HGF-induced cortical neuron migration was assayed either without any electroporation or 
24 hours after electroporation of YFP, Mig6FL-His or Mig6FL-V5 expression plasmids. 
Quantification of all (transfected and untransfected) cells on the lower face of the porous 
membrane revealed a 3 to 4-fold increase of migrated cells in the presence of HGF, and a 
7 to 8-fold stimulation among the GFP-transfectants. In contrast, overexpression of 
Mig6FL-His completely prevented HGF from inducing cell migration (Fig.33). 
 
Figure 33. Overexpression of Mig6 inhibits 
HGF-mediated cortical neurons migration 
HGF-induced cortical neuron migration was 
assayed either without any electroporation 
(transfection -), with GFP (transfection GFP) or 
Mig6FL-His (transfection Mig6FL-His) expression 
plasmids. Quantification of Hoechst positive 
cortical neurons on the lower face of the 
membrane. Non electroporated, GFP or Mig6FL-His electroporated cortical neurons were seeded 
onto the upper side of the Boyden chamber in the presence (black bars) or the absence (gray 
bars) of 50ng/ml of HGF. The cells were left to migrate for 24h, fixed and positive Hoechst nuclei 
counted. Mig6 was found to inhibit completely HGF-induced migration in primary cortical 
neurons culture (Experiment performed by Fabienne Lamballe) 
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In a separate set of experiments the cells both in the upper and in the lower face of 
the membrane were counted. The percentage of cell in the lower face of the membrane in 
respect to the cell in the upper one was also calculated, having therefore a precise 
normalization of the migrating cells in respect to the total number of seeded one (Fig 
34A,B). The cells transfected with plasmids encoding either the control LacZV5 or 
Mig6FL-V5 in the absence or presence of HGF were compared. While LacZV5 control cells 
responded to HGF with a 6 to 7-fold higher migration rate, Mig6FL-V5 expressing cells 
significantly reduced the HGF-mediated migration (figure 34A, p<0.0001, t-test). 
Furthermore, the overall ability of the cells to migrate and the specificity of Mig6 to 
inhibit HGF-mediated migration were assessed. Cells transfected with either LacZV5 
control plasmid or Mig6FL-V5 plasmid were stimulated with stromal cell-derived factor1 
(SDF1) and the migration assay performed. Mig6FL-V5 overexpression was found to be 
unable to inhibit the SDF1-mediated cortical neurons migration (figure 34B, p>0.28, t-
test). 
Mig6 overexpression was found therefore to inhibit HGF-mediated migration in 
MLP29 and in the more physiological system represented by the embryonic primary 
cortical neurons. Since Mig6 overexpression was not able to block SDF1-mediated 
migration, these data suggested that Mig6 is not affecting the overall ability of the cells to 
migrate but its action is rather specific for the HGF-mediated migration signals. 
 
 
Figure 34. Mig6 specifically inhibits 
HGF-mediated migration of cortical 
neurons 
Quantification of migrating electroporated 
cortical neurons (see above and methods) 
with either LacZV5 control plasmid or 
Mig6FL-V5 in the presence of either 
50ng/ml of recombinant HGF (p<0.0001, 
t-test) (A) or 100 ng/ml SDF1 (p>0.28, t-
test)  (B). Mig6FL-V5 was found to 
specifically inhibit HGF-mediated cortical neurons migration.  
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Mig6 suppresses HGF/Met-mediated neuronal differentiation 
 
Besides regulation cell migration, HGF is known as a chemo-attractant and 
neurite outgrowth promoting factor for subsets of central and peripheral neurons, 
including sympathetic neurons (Maina et al., 1998; Yang et al., 1998) (Thompson et al., 
2004). To explore if Mig6 had a more general role in inhibiting HGF responses apart 
from cell proliferation and migration, the effects of Mig6 on neurite outgrowth of post 
natal primary sympathetic neurons was tested in collaboration with Jane Thompson and 
Alumn Davies. Postnatal sympathetic neurons of the Superior Cervical Ganglion (SCG) 
survive in culture without addition of neurotrophic factors. Primary culture of dissociated 
SCG neurons were grown for a short time in culture before being stimulated with 
40ng/ml of HGF for different time. Total proteins were extracted and analyzed by 
western blotting using the Mig6 specific antibody. As shown in figure 35 SCGs neurons 
were found to up-regulate Mig6 protein in response to HGF stimulation. In this case 
western blot using the Map kinase specific antibody was used as an internal protein 
loading control. 
 
 
 
Figure 35. 
P40 SCGs up-
regulate Mig6 
upon HGF 
stimulation. 
Time course of 
Mig6 protein 
induction upon HGF stimulation. Western blot analysis of post natal SCG neurons. Total lysate 
was extracted from SCG neurons and analyzed by western blotting using either Mig6 specific 
antibody (α-Mig6). Map Kinase specific antibody (α-MAPK) was used as a protein loading 
control (experiment performed by Jane Thompson). 
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SCG neurons responded to exogenous HGF with increased outgrowth and 
branching of neurites (Maina et al., 1998; Thompson et al., 2004). To quantify this effect, 
the cells were transfected with an expression plasmid encoding YFP. The plasmid was 
transfected into the post natal SCG using the gene gun and Scholl analysis (see Methods) 
was used to determine neurite complexity. HGF (10 ng/ml) significantly increased neurite 
complexity and increased neurite branching as compared to non-treated control cultures 
(Fig.36A and 37C). The effect was most pronounced close to the soma, while there was 
no significant increase in complexity in the longest neurites (Fig.36A). To investigate a 
role of Mig6 in regulating neurite complexity, the neurite arbors of cells transfected with 
expression vectors encoding Mig6 plus YFP with cells expressing YFP alone was 
compared (Fig.36 B and 37C). Overexpression of Mig6 greatly reduced neurite 
outgrowth and branching of HGF-stimulated cells (Fig.36B). The effect was most 
pronounced close to the cell soma, where HGF had its strongest effects in comparison to 
control cDNAs such as YFP (Fig.36A). This effect was specific for HGF treated neurons, 
since in untreated neurons, expression of Mig6 did not cause a reduction of branch points 
(Fig.37C). 
 
 
 
Figure 36. Mig6 completely abolish HGF-mediated neurite outgrowth in P20 SCGs 
(A) Scholl analysis (see methods) of P40 SCG neurons transfected with YFP alone and exposed 
for 48h to either control media (Con/YFP, gray bars) or 10 ng/ml HGF (HGF/YFP, black bars). 
(B) Scholl analysis of P40 SCG neurons stimulated with 10 ng/ml HGF after being transfected 
with either YFP (black bars) or YFP together with Mig6FL-V5 (gray bars). Mig6FL-V5 expression 
was able to completely block HGF-induced neurite outgrowth (compare panels D and E, gray 
bars) (experiment performed by Jane Thompson). 
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Figure 37 A and B shows representative pictures of SCGs neurite arbors 
expressing either YFP alone (Fig.37A) or YFP plus Mig6 constructs (Fig.37B). 
Furthermore the branch points per neuron in different experimental conditions were 
counted (Fig. 37C). Accordingly to Mig6’s role in the reduction of HGF-mediated neurite 
complexity, the increase in branch point number upon HGF stimulation was found to be 
completely abolished by the overexpression of Mig6 protein (Fig. 36C, compare 
HGF/YFP, HGF/MIG and CONT/YFP).  
Since HGF and Met increase the survival rate of the neurons in culture we next 
assessed whether Mig6 overexpression was able to suppress survival. Surviving neurons 
in the presence of HGF were transfected with a control LacZV5 construct or with Mig6FL-
V5 construct and counted after 48 hours in culture. As shown in figure 38 Mig6 
overexpressing neurons did not show any difference in survival rates in comparison to 
control transfected neurons, suggesting that Mig6 specifically inhibited Met signaling 
towards neurite growth. 
 
 
Figure 37. Mig6 completely 
abolish HGF-mediated neurite 
outgrowth in P20 SCGs 
(A,B) Representative postnatal 
SCG neurons transfected with 
either YFP (A) or with a mixture of 
YFP and Mig6FL-V5 expression 
plasmids (B). Cells were grown in 
medium supplemented with 
10ng/ml HGF for 48h. Note the 
significant reduction in neurite 
complexity of the Mig6FL-V5-expressing cell compared to YFP control. (C) Numbers of neurite 
branch points per neuron in different experimental conditions. P40 SCG neurons were treated as 
described above and the numbers of branch points per neuron counted in the presence (HGF) or 
the absence (CON) of 10ng/ml HGF (experiment performed by Jane Thompson). 
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Figure 38. Mig6 specifically 
inhibited Met signaling 
towards neurite growth 
Percentage of surviving P40 
SCG neurons in different 
experimental conditions. After 
24h HGF exposure, the neurons were transfected with either the control LACZV5 (black bar) or 
the Mig6FL-V5 (gray bar) expression plasmids. Upon stimulation with HGF the expression of 
Mig6FL-V5 did not affect P40 SCG neuron survival (experiment performed by Jane Thompson). 
 
 
Next, Mig6 knock down experiments were performed revealing a modest increase 
in neurite length in mig6 siRNA-treated as compared to GFP siRNA-treated cells 
(Fig.39). The increase of neurite length due to Mig6 knock down was significant in 
processes extending furthest away from the soma. Since the induction of endogenous 
Mig6 protein is delayed (see Fig.35), the effect of knocking down mig6 mRNA may be 
visible only in the longest neurons that took the longest time to grow. These results 
suggested that Mig6 plays a role in suppressing neurite complexity induced by HGF/Met 
signaling. 
 
 
Figure 39. Mig6 knock down in 
P40 SCG modestly increase in 
neurite length 
Sholl analysis of SCGs neurons 
transfected with either mig6 
specific siRNA oligos together with 
YFP (gray bars) or with YFP alone 
(black bars) in the presence of 
10ng/ml HGF. Endogenous Mig6 
knock-down by siRNA induced an 
increase of neurite branching 
(experiment performed by Jane Thompson).  
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The CRIB-domain of MIG6 is required and sufficient to inhibit HGF-mediated cell 
migration 
 
The mechanism of action of Mig6 downstream of EGFR/ErbB appears complex, 
is not well understood, and in part controversial. Mig6 was proposed to inhibit EGFR 
signaling by direct binding to EGFR and ErbB2, by suppressing the EGFR kinase 
activity, but also by a receptor distal mechanism (Anastasi et al., 2003; Fiorentino et al., 
2000; Hackel et al., 2001; Xu et al., 2004). To begin dissecting the mechanism of Mig6-
mediated inhibition of Met signaling, we asked whether Mig6 would directly bind Met in 
MLP29 cells stimulated with HGF. In pull-down experiments using bacterially-
expressed, GST-tagged, purified full-length Mig6, direct association between Mig6 and 
Met was not found. Moreover, the minimal region that had been mapped in EGFR to be 
essential for the binding of Mig6 was not found in the amino acid sequence of Met (data 
not shown). Pull-down experiments with GST-tagged Mig6 did, however, confirm the 
association with Grb2 (Fig.40), which had previously been observed (Fiorentino et al., 
2000). Control pull-downs with GST-tagged P21-associated serine/threonine kinase (Pak) 
failed to pull down Grb2 (Fig.40). This suggested the possibility that Mig6 may bind Met 
indirectly via Grb2 thereby inhibiting Met in a receptor-proximal fashion.  
 
Figure 40. Mig6 binds Grb2 in-vitro 
GST-Mig6FL and GST-Mig6ΔCRIB 
purified fusion proteins were used to 
pull down endogenous Grb2 from 
MLP29 total cell lysate. The fusion 
proteins were incubated for 1 hour 
with total cell lysate and pulled down 
using glutathione-sepharose beads. Pulled down proteins were eluted from the beads and 
analyzed by SDS PAGE. Western blot analysis using an α-Grb2 antibody showed that Grb2 
associates with Mig6 independently of its CRIB domain. A GST-PAKBD fusion protein was used 
as a negative control 
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Next, the relevance of the Mig6 CRIB domain which had previously been 
suggested to bind the Rho family GTPase Cdc42 (Makkinje et al., 2000) was addressed. 
HGF had been shown to activate Rho-family GTPases in epithelial cells concomitant 
with a cell spreading response. Moreover, HGF-induced cell spreading was inhibited by 
dominant negative Cdc42 or Rac (Royal et al., 2000). Mig6 shares striking homology 
with the non-catalytic region of the cytoplasmic tyrosine kinase ACK which interacts 
with Cdc42 via its CRIB domain and inhibits Cdc42’s GTPase activity ((Mott et al., 
1999) and references within). We therefore asked if the CRIB domain of Mig6 was 
essential for Mig6’s inhibition of HGF-induced cell migration. GST-tagged versions of 
Mig6 lacking the CRIB domain (Mig6ΔCRIB), a truncated N-terminal fragment of Mig6 
including the CRIB domain, but lacking the ACK homology domain (Mig6NT), and the 
isolated CRIB domain only (Mig6CRIB) were generated and expressed in MLP29 cells. 
The mutant proteins were expressed at similar levels and in similar subcellular 
compartments (Fig.41A, B1-B9, C). 
HGF-induced cell migration was analyzed using the Boyden chamber assay. As 
previously observed, HGF stimulation strongly induced cell migration above non-
stimulated control cells (Fig.42). Full-length Mig6 inhibited cell migration 2-fold. In 
contrast, Mig6 lacking the CRIB domain had no effect on HGF-induced cell migration 
(Fig.42C, G). The N-terminal fragment of Mig6 including the CRIB domain (Mig6NT) 
and, more importantly, the isolated CRIB domain (Mig6CRIB), inhibited HGF-induced cell 
migration to an extent comparable with full-length Mig6 (Fig.42D, E, G). The effects 
were specific for HGF-stimulated cells, since cell migration induced by FBS was not 
affected by ectopic expression of Mig6NT or Mig6CRIB (Fig.42F). These results suggest 
that the CRIB domain of Mig6 is essential and sufficient for inhibition of HGF-induced 
cell migration. Moreover, the behavior of Mig6ΔCRIB (lacking inhibitory activity, but 
retaining Grb2 binding activity; see Fig.40) suggested that Mig6 binding of Grb2 is not 
sufficient to mediate inhibition of cell migration. 
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Fig. 41 Mig6 mutant proteins 
are expressed at similar 
levels and in a similar 
subcellular compartment 
(A) GST-Mig6FL, GST-
Mig6ΔCRIB, GST-Mig6NT, and 
GST-Mig6CRIB were transfected 
in MLP29 cells and pulled 
down using glutathione-
sepharose beads. The proteins 
were eluted from the beads and 
analyzed by SDS-PAGE. 
Western blot analysis using an 
α-GST antibody shows that the 
Mig6 fusion proteins were 
expressed at similar levels. 
Transfection with YFP 
expression plasmid was used 
as a negative control for the α-
GST antibody.  
 (B) Immunocytochemistry 
analysis of MLP29 cells 
transfected with Mig6FL-V5 (B1-
B3), Mig6ΔCRIB-V5 (B4-B6) and 
LACZV5 (B7-B9) expression 
plasmids, using α-Mig6 (B1, 
B4, B7) and α-V5 antibodies (B2, B5, B8). The subcellular localization of the recombinant 
Mig6ΔCRIB-V5 protein is not affected by the absence of the CRIB domain (compare B6 and B3). The 
LACZV5 expression construct was used as a negative control for α-Mig6 antibodies.   
(C) Schematic representation of the different GST-Mig6 deletion mutants. Their inhibitory effect 
on HGF-mediated cell migration is indicated as a -. Abbreviations: SH3BM: SH3 binding site; 
14-3-3: 14-3-3 binding region; AH: Ack homology domain; PDZ: PDZ target site (Kay and 
Kehoe, 2004). 
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Figure 42. The CRIB-domain of MIG6 is required and sufficient to inhibit HGF-mediated 
cell migration 
(A-E) Hoechst dye-positive cells that have migrated to the lower face of the Boyden chamber 
upon transfection of either YFP alone (A), or a mixture of YFP and GST-Mig6FL (B) GST-
Mig6ΔCRIB (C) GST-Mig6NT (D) and GST-Mig6CRIB (E).    
(F,G) Quantification of cell migration expressed as fold of induction over unstimulated cells in 
the presence of either 10% FBS (F) or HGF (G). MLP29 cells were either left untransfected or 
were transfected with the indicated GST-Mig6 expression plasmids and seeded onto the upper 
compartment of the Boyden chamber. The N-terminal half of Mig6 (Mig6NT) and its CRIB domain 
(Mig6CRIB) were able to significantly inhibit HGF-mediated migration compared to control cells 
(for both P=0.001, t-test). In contrast, Mig6ΔCRIB was not able to significantly reduce HGF-
mediated migration compared to untransfected control (P=0.88, t-test). 10%FBS-induced cell 
migration was not affected by any of the Mig6 expressing constructs (F). 
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Mig6 antagonizes Met signaling possibly by binding to a Rho family GTPase 
 
Since the CRIB domain of Mig6 was found to be required to inhibit HGF-
mediated migration, we concentrated our efforts in identifying a putative molecular 
mechanism by which the CRIB domain could possibly mediate this function. Mig6 is 
known to be structurally related to the non receptor tyrosine kinase Ack1. The Ack1 
homologue in C.elegans, Ark1, was found to inhibit EGFR functions in vivo (Hopper et 
al., 2000) (Worby and Margolis, 2000). Ack1 is known to bind with high affinity to GTP-
bound Cdc42 via its CRIB domain (Gu et al., 2004) (Mott et al., 1999). Furthermore, the 
isolated CRIB domain of ACK1 was showed to inhibit cytoskeleton rearrangements, 
filopodia and lamellipodia formation (Ahmed et al., 2004). Mig6 was also showed to 
directly bind GTP-bound Cdc42 via its CRIB domain (Makkinje et al., 2000). Since 
GTP-bound state of Cdc42 was showed to be required for HGF-mediated cell scattering 
(Royal et al., 2000), we asked whether Mig6 binding to the active form of Cdc42 was 
required to inhibit HGF-mediated migration. Thus, we tested the direct interaction 
between several Mig6 mutant proteins and either Cdc42 or Rac small GTPases using the 
yeast two hybrid system. Briefly, the system consists of a bait gene (in our case the 
GTPase) which is expressed as a fusion to the Gal4 DNA-binding domain, and of a prey 
gene (in our case Mig6 constructs) which is expressed as a fusion to the Gal4-activation 
domain. The bait and the prey plasmids also code for two essential genes for the yeast 
production of leucine (Leu) and triptophane (Trp). Thus, when the plasmids are 
transfected into yeast, double transformants can be selected on a double drop-out media 
(Leu- and Trp- media). When the bait and the prey recombinant proteins interact in-vivo, 
the DNA-binding domain and the activation domain of GAL4 are brought into proximity 
thus activating the transcription of two further reporter genes, adenine (Ade) and histidine 
(His), allowing selection using a quadruple drop-out media (Leu-, Trp-, Ade-, His-). 
Mig6FL, Mig6ΔCRIB and the CRIB domain alone (Mig6CRIB) were transfected into 
Yeast together with either Cdc42 wild type, Cdc42 dominant active, Rac wild type, or 
Rac dominant active. Double transformants were selected on Trp-/Leu- double drop-out 
agar plate. Four colonies of the double transformants were then tested for direct 
interaction by replating onto quadruple drop-out agar plate. Furthermore Mig6 prey 
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plasmids were compared with the CRIB domain of Ack1 and PAK in the ability to bind 
specifically the GTP-bound form (dominant active form) of Cdc42 or Rac respectively. 
All yeast expressing Mig6, regardless of construct, were found to weakly grow in 
quadruple drop-out media in the presence of either Cdc42 wild type or Rac dominant 
active when compared to the CRIB domain of Ack1 and PAK. The CRIB domain of 
Ack1 is known to bind with high specificity the GTP-bound form of Cdc42 as well as the 
PAK binding domain is known to bind with high specificity the GTP-bound form of Rac. 
However in this assay, the yeast expressing the CRIB domain of Ack1 and PAK were 
able to weakly grow on quadruple drop-out media when co-transfected with Rac and 
Cdc42 respectively. The growth rate of the yeast expressing Ack1 CRIB domain or the 
Pak binding domain together with the unspecific GTPase, was found to be comparable to 
yeast expressing Mig full length in the same conditions. Taken together these results 
indicated that Mig6 can weakly interact with Cdc42 and RhoA, comparable to 
nonspecific affinity of Ack or PAK. Thus, it is conceivable that another member of the 
Rho-like GTPases can more strongly and more specifically interact with the CRIB 
domain of Mig6 
 
Figure 43. Representative direct interaction 
between Mig6, Cdc42 and Rac analyzed by 
yeast two hybrid system. 
Mig6 full length (Mig6F.L.) (left panels) and the 
CRIB domain of either PAK (PAKCRIB) (middle 
panels) or Ack (AckCRIB) (right panels) (prey 
genes) were co transfected into yeasts with wild 
type Cdc42 (Cdc42W.T.), Rac (Rac W.T.) or the 
empty vector (control) (bait genes). The double 
transformant yeasts were selected onto double 
dropout Agar plates (Leu-/Trp-). Direct interactors were assayed by replicating double 
transformants yeasts onto Quadruple DropOut (QDO) selective Agar plates. The yeasts doubly 
transfected with Mig6F.L. and Cdc42 W.T can grow on QDO selective plates comparably to the 
yasts doubly transfected with the AckCRIB  and Rac W.T. Transfection of the empty vector was 
used as control for the ability of the yeasts to grow on QDO plates . 
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Discussion 
 
The complex chain of events that attenuate signal transduction of receptor 
tyrosine kinases is still poorly understood. Recent studies have revealed that negative 
receptor signaling involves intricate interactions between ubiquitin ligases, adaptor 
proteins, inhibitory proteins, cytoplasmic kinases and phosphatases (Dikic and Giordano, 
2003). Some of these negative regulators can act on rather specific targets. For example, 
the protein tyrosine phosphatase PTP1B has been shown to inhibit insulin and insulin-like 
growth factor-I- stimulated signaling; SHP1 and Lnk have been reported to specifically 
inhibit Kit-mediated biological functions; and SLAP has been shown to inhibit PDGFR 
signaling. In contrast, other negative regulators, such as c-Cbl ubiquitin ligase and 
Sprouty, appear to inhibit multiple RTKs and generic signaling pathways (Ostman and 
Bohmer, 2001). Negative regulation of Met signaling is particularly critical, since 
deregulation of Met activity is believed to be causative in the development of many 
human malignancies (Birchmeier et al., 2003; Comoglio and Boccaccio, 2001). The same 
is true for the ErbB family of RTKs, which are already targets for anti-tumor therapy 
(Rowinsky, 2004). 
Work presented in this thesis has demonstrated that Mig6 is induced by HGF in 
multiple cell lineages. Mig6 negatively regulates HGF/Met-mediated cellular responses, 
including cell migration and neurite outgrowth, suggesting that Mig6 negatively controls 
Met signaling, thereby fine tuning signaling output. Although further experiments are 
needed to clarify the exact mechanism of Mig6 action, the data suggest an important role 
for Mig6 interaction with Rho family GTPases.  
 
Transcriptional profile of HGF-stimulated MLP29 
 
MLP29, C2C12 and TS cells responded to HGF stimulation in a similar manner. 
HGF induced MAPK, Akt and Gab1 phosphorylation was comparable in time-course and 
strength of activation (Fig.10). Because MLP29 cells were found to enter S-phase 
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(Fig.12) and to scatter upon HGF stimulation they were chosen as a model to characterize 
genes transcriptionally regulated by HGF/Met signaling. 
The microarray data and their validation by northern blot analysis in different cell 
lines (MLP29, C2C12 and TS cells) provided evidence that the majority of the 
transcriptionally regulated genes were targets of HGF signaling (Fig.14) in multiple cell 
types. These data raised the interesting possibility that the newly identified genes had an 
essential role in regulating HGF/Met functions.  
Next, the specificity of transcriptional regulation of target genes was addressed by 
comparing induction via HGF to induction via FGF2 and PDGF. Consistent with the 
observation that the growth factors we tested can activate a similar array of signal 
transduction pathways, they were also found to transcriptionally regulate common genes. 
Mig6 was unusual in that and HGF was found to be the main inducer, compared to FGF2 
and PDGF, of mig6 transcript (Fig.17). This observation supports a model in which each 
receptor emits, above a generic signaling threshold, qualitatively different signals 
resulting in differences in transcriptional response and these specific targets contribute to 
specific functions. Indeed, Mig6 was found to specifically inhibit HGF-mediated cell 
motility, which is the most characteristic function mediated by this growth factor. 
Taken together, these results suggest that different tyrosine kinase receptors share 
activation of common downstream signaling pathways and part of their transcriptional 
response as well. Nevertheless the RTKs we tested retained portion of regulated 
transcripts unique to them. It is reasonable to think that the specificity of transcriptional 
regulation for each receptor may be responsible for the differences in the functions that 
each receptor can mediate. 
 
Mig6 induction by external signals 
 
Mig6 was identified in MLP29 cells as a transcript highly induced by HGF, and 
rather weakly by FGF2 and PDGF. Other investigators founded Mig6 induced by serum, 
EGF and related ligands, and cellular stress factors (Chu et al., 1988; Wick et al., 1995) 
(Makkinje et al., 2000) and references within). The time course of Mig6 induction 
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appeared to depend mainly on the external signal (PDGF causing a transient and EGF 
causing sustained induction of Mig6 (Xu et al., 2004). The strength of induction appeared 
to depend more on the cellular context than on the type of external signal. MLP29 and 
C2C12 cells showed very robust (on average >10-fold) transcriptional activation of Mig6 
by HGF, whereas primary hepatocytes induced Mig6 protein approx. 2 to 4-fold (Fig.15 
and 19). Primary sympathetic neurons were found to upregulate Mig6 in response to HGF 
as well (Fig.35), whereas cortical neurons did not show any induction of mig6 transcripts 
(data not shown). This work provided evidence that Met signaling is a major pathway for 
Mig6 expression in lungs and liver of E13.5 embryos by showing a reduction of mig6 
transcript levels in mouse mutants expressing a severe signaling hypomorph of Met 
(Fig.21).  
Mig6 was frequently found expressed at low levels, and its expression induced by 
HGF/Met signaling with some delay after the initiation of Met signaling. In presence of 
low Mig6 levels the cell will respond robustly to Met signaling until Mig6 levels are high 
enough to attenuate the receptor response. Alternatively, other external signals might 
have already induced the expression of Mig6 before the cells were exposed to HGF, 
thereby reducing the cell’s ability to respond to Met signaling. Loss of the ability to 
induce the expression of Mig6 might be part of the multiple step process towards 
malignancy. Consistent with this model, a recent large-scale expression profiling study 
identified Mig6 expression to be downregulated in breast cancer patients with short 
survival time (Amatschek et al., 2004). It appears that loss of Mig6 provides a growth 
advantage and perhaps metastatic potential for breast cancer cells. 
 
Mig6 modulates a variety of cellular responses  
 
Previous work had shown that Mig6 inhibits cell proliferation downstream of 
ErbB family receptors (Anastasi et al., 2003; Fiorentino et al., 2000; Hackel et al., 2001). 
This includes a recent study in which Mig6 was silenced by RNA interference providing 
first evidence for a role as an endogenous inhibitor of EGFR-mediated proliferation (Xu 
et al., 2004).  
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The work presented in this thesis has concentrated on the role of Mig6 in Met-
mediated cell migration, although the data presented also provides evidence that Mig6 
inhibited the mitogenic activity of Met (Fig.30). However these data suggested that the 
mig6 knock-down by siRNA in MLP29 cells is sufficient to increase the number of cells 
entering S-phase independently of HGF stimulation. Thus, Mig6 may be also part of a 
HGF-independent pathway that regulates the cell cycle of MLP29 cells via a mechanism 
that is still unknown.  
The inhibition of HGF-dependent migration via Mig6 was found to be 
independent of the previously known Mig6 anti-mitogenic effect. HGF-mediated cell 
migration has been studied in a number of different cellular contexts, including myoblast 
migration during development, scattering and branching morphogenesis of epithelial 
cells, neuronal migration in the developing forebrain (Powell et al., 2001) (Birchmeier et 
al., 2003; Rosario and Birchmeier, 2003). Mig6 overexpression was found to effectively 
and specifically reduce HGF-induced migration of a hepatic cell line and of primary 
cortical neurons. In converse experiments, mig6 knock down effectively enhanced cell 
migration of hepatic progenitor cells. Furthermore, the data presented here suggested that 
Mig6 overexpression does not influence the overall cell migration capability. In fact, the 
migration of MLP29 and cortical neurons stimulated with 10% serum and SDF1 
respectively was not affected by Mig6 overexpression. These results suggested that the 
inhibitory function of Mig6 did not affect general cell motility mechanisms but rather 
specific signaling pathways responsible for HGF-mediated cell migration. This data 
provided first evidence that Mig6 plays a specific role in regulating HGF-mediated 
migration independently of its anti-mitogenic function. 
The role of Mig6 in ErbB-mediated cell migration has still not been addressed. 
This is will have to be addressed in the future, since numerous studies have demonstrated 
that EGF and related ligands for EGFR/ErbB receptors stimulate chemotactic responses 
in vertebrate and invertebrate systems (Caric et al., 2001; Gambarotta et al., 2004; 
Marone et al., 2004; Wells and Lillien, 2004). 
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Mig6 negatively regulates HGF-mediated neurite extensions and branching but not 
survival of sympathetic neurons 
 
Central nervous system development is also characterized by invasive growth. 
The precise anatomical connections that are required for the central nervous system’s 
functions rely on the directional movement of axons that sprout and branch following 
extracellular signals that determine their motile activity (Yu and Bargmann, 2001). 
Indeed, Met signaling is critical for neurite extension and branching of different neuronal 
subpopulations (reviewed in (Maina and Klein, 1999); see also (Thompson et al., 2004), a 
process that has similarities with invasive growth of malignant cells (Trusolino and 
Comoglio, 2002). This study provided evidence that Mig6 overexpression effectively 
blocked HGF-induced neurite outgrowth of primary sympathetic neurons without 
affecting HGF-mediated survival of the neurons. Conversely, mig6 knockdown 
moderately enhanced HGF-mediated neurite outgrowth of sympathetic neurons. It has to 
be noted that since Mig6 protein, in the SCG, is induced after 16 hours from HGF 
stimulation (Fig.35), the reduction of neurite length due to the knock-down of the 
endogenous Mig6 is relevant when quantified at higher distances from the cell soma 
(from 210µm to 380µm) (Fig.39). Conversely, the decrease in neurite branching due to 
Mig6 overexpression was found to be signicant at distances closer to the cell soma (from 
60µm to 240µm) (Fig.36B). Therefore, exogenously supplied Mig6 immediately blocked 
HGF-dependent neurite extension, resulting in a general decrease of neurite complexity. 
On the other hand, the endogenous Mig6 protein exerted its inhibitory effect only after 16 
hours upon HGF stimulation. Most probably HGF induced the outgrowth of primary 
branches close to the cell soma prior to substantial Mig6 expression and then promoted 
the outgrowth of neurites further from the cell soma. In this model, the increasing level of 
Mig6 protein would limit limit later HGF-mediated neurite growth. These data suggested 
that endogenous Mig6-effect inhibits the HGF-mediated growth of specific neurites that 
extend far from the cell soma.  
Mig6 was found to inhibit HGF-mediated neurite outgrowth but not survival 
consistent with a role in the inhibition of specific Met-mediated functions. These data, 
together with the observation that Mig6 overexpression affected only migration in 
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cortical neurons (while neurite growth and survival were found unaffected), suggested 
that Mig6-mediated inhibition is limited to specific Met-mediated effects in a cell specific 
manner. It is likely that Mig6 inhibits a Met-activated signaling pathway, which results in 
cell motility, in the context of MLP29 and cortical neurons, and in neurite outgrowth, in 
the context of SCG neurons. 
These data support the idea that Mig6 inhibits specific pathways downstream of 
Met without affecting its overall functions, therefore fine tuning the receptor output. 
Furthermore, these data represent the first evidence that Mig6 plays a crucial role in the 
inhibition of specific HGF-mediated effects on sympathetic neurons. 
 
Mig6 and Met are partially coexpressed in the somites and in the developing 
muscles 
 
Work presented here demonstrates that at E9.5 mig6 mRNA is expressed in 
developing somites (Fig.20). Interestingly mig6 was found to be expressed in the medial 
region of the forming somites, which later give rise to epaxial muscles (deep back 
muscles). Mig6 was also found in the more medio-lateral region that is known to give rise 
to hypaxial muscles (most body and limb muscles). Conversely, met mRNA expression 
was confirmed to be restricted to the most lateral domain of the somites. Whithin this 
somitic domain, met transcripts only partially co localized with mig6 mRNA. 
Intriguingly, a recent study (Chung et al., 2004) has reported an essential role for the 
Xenopus homologue of Mig6 (XMig6) during muscles differentiation. In particular, 
Xmig6 was found to be a potential downstream transcriptional target of eFGF with 
specific roles in muscle differentiation. Xenopus embryos in which mig6 was knocked 
down by siRNA were reported to have a significant down-regulation of the early 
myogenic marker Mif5 and to lack well-differentiated muscles. Low level of Mig6 may 
therefore act during early myogenesis to allow the migratory Met-positive muscle 
precursors to properly migrate toward their final targets. Subsequently, once the cells 
reached their target tissues and migration ceases, prolonged HGF signaling together with 
other extracellular signals (such as FGF) may induce Mig6 expression. Mig6 may 
therefore participate to attenuate Met signals. Consistent with this model, the termination 
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of Met signals is required for the muscle precursors to express myogenic genes (such as 
Myf5 and MyoD) (Scaal et al., 1999). Because the loss of Met functions in embryos does 
not affect the expression of early myogenic genes (Mif5 and MyoD) (Prunotto et al., 
2004) (Maina et al., 1996) and since Mig6 can drive the expression of Mif5 (Chung et al., 
2004), Mig6 may also contribute to muscle differentiation in a HGF-independent manner. 
Consistent with this model, HGF is expressed along the entire route followed by the 
migratory myoblasts, that in turn express Met until they reach their final target tissue 
(Dietrich et al., 1999). The prolonged requirement for an active Met signaling during long 
range migration may also address the need of the muscle precursors to maintain the 
undifferentiated state (Scaal et al., 1999) and to sustain their proliferation and survival 
(Ponzetto et al., 2000). However, Met signals needs to be tightly regulated in space and 
time during muscle development. Mice expressing HGF ectopically showed an aberrant 
development of muscles around the spinal cord (Takayama et al., 1996) implying that an 
excess of Met signaling in muscle precursors results in the misrouting of migratory 
myoblasts and in the development of an aberrant phenotype. Furthermore, accordingly to 
the essential role played by Met during the formation of secondary muscle fibers (Maina 
et al., 1996) (Maina et al., 2001) mature hypaxial muscles fibers (intercostal, body wall 
and limb muscles) were confirmed positive for met expression (Fig.21 and not shown). 
Interestingly, the hypaxial muscle fibers were found positive for mig6 expression as well 
(Fig.21 and 22 and not shown). Therefore, whether Mig6 plays a role during myoblast 
migration and muscle differentiation in a HGF dependent and/or independent manner, is 
an important question that will have to be addressed in the future. 
 
Mig6 acts distally from Met via interaction with Rho family GTPases  
 
The cDNA for Mig6 is predicted to encode a cytosolic polypeptide of 459 amino 
acids with the attributes of an adaptor protein. The first 38 amino acid residues in the 
amino terminus of Mig6 show significant homologies with the conserved Cdc42/Rho 
Interacting Binding domain (CRIB domain) which is present in several other proteins. 
Mig6 also contains other conserved domains, among them a putative binding site for 
SH3-containing molecules (a.a. 146-160) which has been shown to bind Grb2, PI3K and 
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PLCγ (Fiorentino et al., 2000); a 14-3-3 binding region (a.a. 246-253); and a putative 
binding motif for PDZ domain containing proteins. Notably, Mig6 also includes a C-
terminal motif highly homologous to the non-catalytic portion of ACK1. A region within 
this ACK1 Homology domain (AH domain) was previously identified as an EGFR 
binding motif (Fiorentino et al., 2000) (Anastasi et al., 2003), and more recently the AH 
domain of Mig6 has been shown to be necessary and sufficient for the inhibition of 
EGFR (Xu et al., 2005). Although Mig6 was found unable to directly bind Met, the 
observation of molecular association between Mig6 and Grb2 (Fig.40) suggested the 
possibility that Mig6 may bind Met indirectly, thereby inhibiting Met in a receptor-
proximal fashion. 
The CRIB domain of Mig6 has been reported to bind Cdc42 in a GTP-dependant 
manner (Makkinje et al., 2000). The activation of Cdc42 downstream of HGF stimulation 
is required for lamellipodia formation and cell movement (Royal et al., 2000). This raised 
the possibility that Mig6, via its CRIB domain, inhibits Cdc42-mediated cell movement. 
Results in this thesis are consistent with this model. This study provides evidence that the 
CRIB domain of Mig6 is sufficient and required for the inhibition of HGF-mediated 
migration. Overexpression of a Mig6 construct lacking the CRIB domain, but retaining 
Grb2 binding capabilities, did not suppress HGF-induced migration. Conversely, 
overexpression of the Mig6 CRIB domain alone is sufficient to inhibit HGF-mediated 
migration. These data also indicate that the association between Mig6 and Grb2 is not 
sufficient to inhibit cell migration. The mechanism of Mig6 inhibition of Met therefore 
resembles the mechanism of Ack1 inhibition of EGFR. The C. elegans orthologue of 
Ack1, Ark, associates with EGFR via binding to Sem5, the C. elegans orthologue of 
Grb2 (reviewed in ((Worby and Margolis, 2000). Similar to Mig6, overexpression of the 
CRIB domain of Ack was found to be sufficient to inhibit growth factor induced 
activation of Cdc42 (Nur et al., 1999). The possible involvement of the Mig6 CRIB 
domain in the negative regulation of HGF-mediated cell movement is also supported by 
the observation that the overexpression of the CRIB domain of Ack is sufficient to inhibit 
Cdc42-mediated cell growth and movement (Ahmed et al., 2004). Furthermore the 
overexpression of the CRIB domain of another small GTPase-binding protein (PAK, an 
effector of Rac1) via its interaction with Rac1 was found to inhibit the Sema3A- (a 
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repulsive factor for specific neuro population) growth cone collapse (Vastrik et al., 1999). 
Together these results suggested that CRIB domains inhibit specific GTPases, possibly 
by competing with alternate downstream effectors.  
The involvement of a Rho-like GTPase and the CRIB domain of Mig6 in the 
regulation of HGF-mediated biological functions is furthermore supported by 
experiments conducted in SCG neurons. Activated mutants of Cdc42 and Rho are known 
to induce SCG neuronal death, whereas expression of the dominant negative counterparts 
can protect them from apoptosis, even in the case of trophic factor withdrawal (Bazenet 
et al., 1998). Combining these data with our model by which Mig6 can inhibit/modulate 
Rho-like GTPases, the HGF-mediated survival of SCG neuron was not affected by Mig6 
overexpression. In this case Mig6 overexpression might inhibit or modulate HGF-
mediated GTPase activation, allowing increased neuronal survival. Conversely, 
overexpression of the Mig6 construct lacking the CRIB domain resulted in a significant 
decrease in neuronal survival (not shown). Because the Mig6ΔCRIB protein is unable to 
downregulate HGF-dependent activation of the GTPase, this may result in the increase of 
neuronal death.  
From these data it is possible to picture Mig6 as a molecular switch that 
inhibits/modulates the Rho-like GTPase activity. Further experiments are needed in order 
to establish whether or not the Rho-like GTPase modulation/inhibition via Mig6 is 
required for a correct HGF-mediated migration of MLP29 cells and cortical neurons, and 
to promote a correct survival rate and neurite outgrowth of SCG neurons. 
These are important possibilities that will have to be addressed in the future in 
order to properly characterize the role and mechanism of Mig6 action in the context of 
Met receptor negative regulation. 
 
Concluding remarks 
  
This work inserts Mig6 as a member of a network of negative signaling molecules 
that fine tune and attenuate Met and possibly ErbB signaling in development and disease. 
Mig6 was found to negatively regulate HGF-mediated migration and neuronal 
differentiation. Additional work is required in order to exclude other possible 
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mechanisms of Mig6 action (for example via Grb2, PI3K or 14-3-3) and in order to 
clarify the Mig6’s molecular partners. Nevetheless there is strong evidence that the CRIB 
domain of Mig6, via the interaction with a Rho-like small GTPase, is essential in 
mediating Mig6’s function. The analysis of mig6 null mutant mice is in progress (I. 
Ferby, R. Klein, unpublished) and will help to elucidate the function of Mig6 in the 
context of development and of an intact tissue.  
Finally, the finding that Met biological effects can be limited by modulation of its 
signaling pathways raises the possibility that control of Met-specific effects might be 
obtained by inducing the expression of Met antagonists such as Mig6. The advantage of a 
physiological and specific inhibitor of Met signaling is evident: the metastogenic and 
tumorigenic properties of scatter factors must be separated from their beneficial trophic 
properties. If and how Mig6 contributes to the complex chain of events that drive cancer 
progression and metastasis and whether Mig6 is able to suppress HGF-mediated 
metastogenic effects without perturbing its trophic properties are all fascinating questions 
that deserve further investigations. 
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Materials and Methods 
 
Materials 
 
Metd/d mutants were generated by Flavio Maina (Maina et al., 1996). Mutant mice 
were maintained in a C57/Black6/CD1 mix genetic background. For experiments, only 
offspring of heterozygous intercrosses was used. 
 
Plasmids 
 
Plasmid Insert Comments  Reference 
     
GP6 Mig6 FL C-term V5  Pante et al., 2005 
pDEST26 Mig6 FL C-term His  Pante et al., 2005 
GP15 Mig6 FL N-term GST  Pante et al., 2005 
GP16 Mig6 DCRIB N-term GST  Pante et al., 2005 
GP17 Mig6 N-terminal N-term GST  Pante et al., 2005 
GP34 
Mig6 CRIB 
domain N-term GST  Pante et al., 2005 
pDONOR201    Invitrogen 
pMet-5' Met5' In-situ probe  
Helmbacher et al., 
2001 
pMet-3' Met3' In-situ probe  
Helmbacher et al., 
2001 
h3011f08 
Mig6 partial 
codons 
In-situ/northern 
probe  NIA clone set 
h3046a05 CK334526 Northern probe  NIA clone set 
h3142b10 AK010617 Northern probe  NIA clone set 
h3017h12 h3017h12 Northern probe  NIA clone set 
h3080h11 BG069863 Northern probe  NIA clone set 
h3118f05 BG073094 Northern probe  NIA clone set 
h3011f08 BG063865 Northern probe  NIA clone set 
h3016f11 BC016400 Northern probe  NIA clone set 
h3028f05 BG069647 Northern probe  NIA clone set 
h3057e07 BC025860 Northern probe  NIA clone set 
h3019f06 NM_025448 Northern probe  NIA clone set 
h3090g02 BG070747 Northern probe  NIA clone set 
h3081a04 BG069868 Northern probe  NIA clone set 
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Chemicals, enzymes and commercial kits 
 
Chemicals were purchased from the companies Merk, Sigma, Fluka, and Roth. 
Only in the cases where the suppliers were different it is indicated together with the 
method. All water used to generate solutions was filtered with the “Milli-Q-Water-
System” from Millipore. Restriction enzymes were purchased from New England Biolabs 
(NEB). Special suppliers and kits are mentioned in the methods. 
 
Media and standard solutions 
 
LB (Luria-Bertani) media  10g bacto-trypton 
     5g Yeast extract 
     5g NaCl 
     Add H2O to 1l, pH7.5 
LB plates    supplemented with 15g/l agar 
 
Antibiotics 1000X 
Ampicillin    Stock 100mg/ml in H2O 
Kanamycinsulfate   Stock 50mg/ml 
 
Media and supplements for primary culture 
 
Neurobasal media/B27 Gibco, 500ml were supplemented with 10ml 
of B27 supplement 
 
HBSS Gibco 
 
Supplements Trypsin/EDTA (GibcoBRL) 
 Poly-D-Ornithin (Sigma) 
 Fibronectin (Sigma) 
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Stimulating factors  HGF (R&D) 
 FGF2 (Sigma) 
 PDGF (Sigma) 
 FGF4 (Sigma) 
 
Buffers and solutions 
 
10X PBS 1.3M NaCl 
 70mM Na2HPO4 
 30mM NaH2PO4, pH7.2 
 
TE buffer  10mM Tris/HCl 
 1mM EDTA, pH8 
 
50X TAE 2M Tris-Acetate 
 50mM EDTA 
 
20X SSC 3M NaCl 
 0.3M NaCitrate, pH7.5/4.5 
 
Northern blot  
 
RNA loading buffer  13.4% formamide,  
4.4% of 37% formaldehyde,  
80µg bromophenolblu  
dissolve in 1X MOPS 
  
1X MOPS pH 7    0.418 % MOPS 
2mM Na-Acetate  
1mM EDTA pH 8 
Materials and Methods 
88 
 
 5X Denhardt solution    1% Ficoll 400  
1% polyvinylpirrolidone 
1% BSA 
Dissolve in H2O 
 
Microarray 
  
Hybridization buffer    50% formaldehyde  
6X SSC  
0.5% SDS  
5X Denhardt 
 
Genotyping PCR 
 
Tail lysis buffer    100mM Tris pH7.5  
1mM EDTA  
250mM NaCl  
0.2% SDS 
SiRNA 
 
SiRNA annealing buffer   100mM K-Acetate 
30mM Hepes-KOH 
2mM Mg-Acetate 
 
 
 
In-situ hybridization 
 
Hybridization buffer    0.19M NaCl  
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10mM Tris pH7.2  
5mM NaH2PO4·2H2O  
50mM EDTA  
50% formamide  
10% dextrane sulfate  
1mg/ml Yeast rRNA  
1X Denhardt solution 
 
Washing buffer    50% formammide 
2X SSC 
0.1% tween20 
 
Whole mount in-situ hybridization 
 
Prehybridization solution  50% formamide 
5X SSC pH4.5 
0.1% tween20 
0.5% chaps 
2% blocking reagent 
50μg/ml of tRNA 
50μg/ml heparin 
5mM EDTA pH8.1 
Embryo powder 
 
Several litters of CD1 E12.5 to E14.5 embryos were dissected in PBS and fast 
freezed in liquid nitrogen. The embryos were mechanically destroyed. 
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Antibodies 
 
Primary antibodies  
 
Anti-phospho-MAPK New England biolabs, mouse monoclonal 
 WB 1:5000 
Anti-MAPK New England biolabs, rabbit polyclonal 
 WB 1:1000 
Anti-phospho-AKT New England biolabs, rabbit polyclonal 
 W.B. 1:1000 
Anti-tubulin Sigma, mouse monoclonal 
 W.B. 1:2000 
Anti-phospho-tyrosine (4G10) Upstate Biotechnology, mouse monoclonal 
 W.B. 1:5000 
Anti-Mig6 Pante et al., in preparation, rabbit polyclonal 
     W.B. 1:500, IF 1:250 
Anti V5     Invitrogen, mouse monoclonal 
     IF 1:250 
Anti-BrdU    Boehringer, mouse monoclonal 
     IF 1:250 
Anti GAB1 Gift from Liliana Minichiello, rabbit 
polyclonal 
     WB 1:2000  
Anti Met    Biomol, rabbit polyclonal 
     WB 1:500 
Anti-GST    Santa Cruz, rabbit polyclonal 
     WB 1:500 
 
 
 
Materials and Methods 
91 
Secondary antibodies 
 
Anti-mouse HRP   Amersham, goat polyclonal 
     WB 1:2000 
Anti-rabbit HRP   Amersham, goat polyclonal 
     WB 1:2000 
Anti-mouse texas red   Sigma, goat polyclonal 
     IF 1:200 
Anti-rabbit CY3   Jackson, donkey polyclonal 
     IF 1:200 
Anti-mouse alexa488   Molecular Probes, donkey polyclonal 
     IF 1:200 
Anti-Digoxigenin   Roche, sheep polyclonal 
     In-situ 1:2000 
 
Nuclear staining   Hoechst nuclear stain, Hoechst, IF 1:1500 
 
Glutathyon-sepharose beads  Amersham 
   
 
Methods 
  
Molecular biology 
 
All the molecular techniques, unless otherwise specified, were carried out 
according to Sambrook (Sambrook et al., 1989). 
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Cloning and generation of in-situ and northern blot probes  
 
The V5 C-terminal, GST N-terminal or His C-terminal tagged Mig6 full length 
and mutants proteins were generated using the Gateway Cloning technology according to 
the manufacturer instructions (Invitrogen). Briefly, Mig6 full length and deletion mutants 
were amplified by Polymerase Chain Reaction (PCR) from IRAK clone IRAKp961F0910 
using oligonucleotides containing the minimal recombination sequences (5’-ATTB1 and 
3’-ATTB2). 300ng of the PCR amplified products were recombined into 300ng of the 
pDONOR201 vector (Invitrogen) by the use of a mixture of recombination proteins 
provided by manufacturer. 300ng of the pDONOR201 vector containing Mig6 full length 
and deletion mutants were then shuttled into pCDNA 6.2 C-terminal V5 (Invitrogen), 
pDEST 27 N-terminal GST (Invitrogen) and pDEST26 N-terminal His (Invitrogen) 
plasmids. These plasmids were used for all the Mig6 full length and deletion mutants 
overexpression experiments in mammalian cells. 
For the generation of the in-situ probes 10μg of the plasmid containing either 
Met5’, Met3’ (Helmbacher et al., 2003) or Mig6 (N.I.A. clone H3011F08) were digested 
with enzymes cutting either downstream (for the sense probe) or upstream (for the 
antisense probe) to linearize the plasmid. Following 4h digestion at 37°C the linearized 
plasmid DNA was extracted with phenol/chloroform. Phenol was added to the restriction 
mix (1:1), mixed, and centrifuged for 10 min. at 4°C. The supernatant was extracted with 
1 volume phenol and 1 volume chloroform/isoamylic alcohol (24:1) using the same 
procedure. The supernatant was then incubated with 0.7 volume of isopropanol 20 min at 
-20°C. The purified DNA was then precipitated by centrifugation at 13.000 rpm for 20 
min, washed twice with 70% ethanol and resuspended in 50µl of Tris buffer (10 mM, 
pH8). To generate digoxigenin-labelled RNA probe 1μg of linearized plasmid was 
incubated with transcription buffer (Roche, in-situ probe labeling kit), digoxigenin-
conjugated dNTPs, RNAse inhibitors, and the specific RNA polymerase which would 
recognize a site upstream or downstream of the cDNA insert, for 3h at 37°C. In order to 
precipitate short RNAs, LiCl and 100% Ethanol were added. The mixture was left at -
20°C for 30 min. Subsequently, the mix was centrifuged for 20 min. at 4°C. The 
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precipitated RNA was washed twice with 70% Ethanol and left 30 min. to dry at room 
temperature. The dried pellet was resuspended in 150ul of TE buffer and stored at -80°C. 
For the generation of the northern blot probes the clones selected from the NIA 
library were amplified and the plasmids isolated using the miniprep kit (Qiagen). 5µg of 
the isolated plasmids were digested using NotI and SalI restriction enzymes which were 
universal enzymes for excising the NIA library inserts (Tanaka et al., 2000). The 
restriction digest was then subjected to Agarose gel electrophoresis and the excised insert 
recovered and purified from the gel using the Gel Extraction Kit (Qiagen). 
 
Northern blot 
 
Total RNA was extracted from different cell lines in various experimental 
conditions using the RNAClean Solution (Hybaid) according to the manufacturer 
instructions. The media of cells growing in 10cm dishes was removed and 2ml of 
RNAClean solution was added. After resuspending the cells several times by passing 
through a pipette tip the solution was transferred on ice and 200μl of chloroform added. 
The solution was incubated for 5 min. on ice and centrifuged at 12.000 rpm for 15 min. 
The aqueous phase was transferred into a fresh tube and the total RNA precipitated by 
adding an equal volume of isopropanol. The samples were then incubated at -20°C for 20 
min. The total RNA was harvested by centrifugation at 12000 rpm for 20 min. The RNA 
pellet was washed twice with 70% ethanol and dried completely. Total RNA was then 
resuspended in 100μl of RNAse-free water. The quality and concentration of the total 
RNA were checked by Agarose gel electrophoresis and further confirmed reading the 
absorbance of the sample at 260 and 280 nm. 
30μl of loading buffer was added to 20μg of RNA and each sample was brought 
to a total volume of 40μl. The RNA was denatured by heating at 60°C for 10 min. The 
samples were then chilled on ice for 5 min. and loaded on a gel containing 1% Agarose, 
1.8% formaldehyde dissolved in 1X MOPS. The total RNA was then blotted by 
capillarity on the Genescreen nylon membrane (NEN life science) according to standard 
procedures. The membrane was saturated at 65°C for 3 hours in a blocking solution 
containing 6X SSC, 5X Denhardt solution and 100μg salmon sperm. 
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The purified probes were radio-labeled using the random prime labeling system 
(RediprimeTMII, amersham pharmacia biotech). 100ng of the probes were denaturated at 
95°C for 5 min. and then incubated for 1 hour at 37°C with a solution containing DNA 
polymerase, random primers and a dNTPs mix with [32P ] dCTP (amersham pharmacia 
biotech). The radio-labeled probe was then separated from the unincorporated labeled 
dCTP by the use of ProbequantTM G-50 Micro columns (amersham pharmacia biotech) 
according to the manufacturer instructions. 
The radiolabelled probe was then diluted in 10ml of hybridization solution (6X 
SSC, 5X Denhardt solution and 100μg salmon sperm) for 18 hours at 65°C. The 
membrane were subjected to several washes of 15 min. at 65°C progressively increasing 
the stringency of the solution (1st wash: 2X SSC, 0.1% SDS; 2nd wash: 0.5X SSC, 0.1% 
SDS; 3rd wash: 0.2X SSC). The membranes were then exposed either to X-ray film 
(Kodak) for 18 hours at -80°C or to the phosphoimmager detection screen for 3 hours in 
order to quantify the signal.   
 
Microarray production and probe labeling 
 
Global gene expression was analyzed using a cDNA microarray. The high-density 
glass microarray chips were prepared at the EMBL core facility by the use of the NIA 
15K cDNA mouse clone set (Tanaka et al., 2000). The NIA 15,247 mouse library was 
first replicated inoculating 2μl of the original bacterial suspension into 50μl of LB broth. 
The replica plates were incubated 18 hours at 37°C. 1ul of the bacteria replica culture was 
then amplified by PCR using two universal oligonucleotides. The 15,247 PCR products 
were further purified from unincorporated dNTPs and oligonucleotides using the PCR 
purification kit (Macherey-Nagel). The purified PCR products were eluted in 100μl TE 
buffer. The size and quality of the PCR amplified products were then controlled by 
Agarose gel electrophoresis. The PCR amplified products were spotted at high density on 
glass coverslips by the use of a spotting device. The spotted slides were further incubated 
at 50°C for 3 hours and the DNA was denatured at 100°C for 10 min. The microarray 
slides were then stored at room temperature in a dark place.  
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Total RNA was extracted from different cell lines under different experimental 
conditions using the RNAClean Solution (Hybaid) as described above. 40μg of total 
RNA was then retro-transcribed and fluorescently labeled using a mixture of 3μg poly-dT 
oligonucleotide (GIBCO), 6µl of retro-transcriptase superscript II (GIBCO), 0.1M DTT, 
3μl of either Cy3-dUTP (Amersham) (for the RNA derived from the unstimulated cells) 
or Cy5-dUTP (Amersham) (for the RNA derived from the stimulated cells) and 25μM of 
dNTPs. The retro-transcription reaction was incubated for 4 hours at 42°C and stopped 
with 1.5μl of 1M NaOH/20 mM EDTA. The labeled cDNA was then purified using the 
PCR purification kit (Qiagen). Thus, the cDNA probes derived from untreated or from 
variously stimulated cells were fluorescently labeled with Cy3-dUTP (green) or Cy5-
dUTP (red), respectively.  
 
Microarray hybridization 
 
The microarray cDNAs were denatured for 2 min. in boiling water before the 
hybridization with the cDNA probes. The Cy5 and Cy3-labelled cDNA probes were 
mixed, dried and resuspended in 30μl water. 2.4μg salmon sperm DNA, 10μg Poly-dA 
oligonucleotide (Invitrogen) and 24μl hybridization buffer was added to the cDNA 
probes and the mixture denaturated by incubation for 2 min. at 95°C. The cDNA probes 
were then hybridized on the microarray slide and incubated for 16 hours at 42°C in a 
water bath. After the hybridization, the Microarray slide was washed twice with 0.1X 
SSC, 0.1% SDS for 10 min. at room temperature and twice with 0.5 X SSC for 10 min. 
Finally, the two fluorescent images were scanned with a fluorescence laser-scanning 
device (Gene pix 400B, Axon instruments).  
 
Microarray analysis 
 
The hybridizations were performed in duplicate using total RNA samples 
extracted from two independent batches of cultured cells. 
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Green and red fluorescent signals indicated genes whose expression levels were 
relatively higher in cells untreated or HGF-stimulated, respectively. The differential 
expression of each gene was calculated from the relative intensity of the Cy5 versus Cy3 
fluorescent signals. Two independent experiments were conducted comparing untreated 
cells and cells stimulated with HGF for 4 hours and one experiment was conducted 
comparing two 4 hours HGF-stimulated samples (background control). 
The data acquisition and initial data analysis was performed with GenePix Pro 3.0 
and the data tables were analyzed further in Microsoft Excel in order to obtain the gene 
list. Quality control was performed, firstly by eye, to confirm scanner alignment and 
absence of significant bubbles and scratches. Scatter plots were further used to eliminate 
unacceptable hybridization data. The multiple spike-in controls RNA template were 
added to the sample upon direct labeling, and the successful labeling and hybridization 
was confirmed in each hybridizations (Richter et al., 2002). 
GenePix Pro program calculates the normalization factor of each hybridization, 
based on the premise that the arithmetic mean of the ratios from every feature on the 
given array should be equal to 1. Normalization was therefore performed by multiplying 
the factor to Ratio of Medians (ROM) in each gene. The genes that passed all these 
criteria were first sorted by Sum of Median (SOM), which indicates the intensity of 
hybridization. In order to obtain the list of genes that are relatively abundant, the genes 
that showed more than 5,000 of SOM were selected. Finally, the genes were sorted by 
ROM. The genes that showed more than ±1.8 fold changes were selected in the data table 
from each hybridization. Finally, the data tables were compared between the two 
hybridizations and average ROM was calculated. Gene functions were categorized based 
on the information given in the NIA mouse 15k cDNA clone gene ID list at the first 
instance and modified when necessary. 
 
Tail DNA preparation and genotyping PCR 
 
Genetic determination of mice was done using PCR analysis. Tail biopsies were 
taken from the mice at weaning age of about 3 weeks. For genotyping embryos, the 
amniotic tissue was collected and washed several times with PBS to avoid possible 
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contamination with maternal tissue. 2-5mm of tail were cut and incubated overnight at 
56°C with tail lysis buffer plus 100µg/ml of Proteinase K (Quiagen). The proteinase K 
was inactivated by heating the solution at 95°C for 10 min. The solution was then diluted 
2.25 times with water and 1µl of this DNA solution was used for PCR analysis. 17.5pM 
specific primers to amplify a sequence of the genomic DNA specific for an allele were 
added together with PCR buffer (Perkin Elmer), dNTPs, and Taq polymerase (Perkin 
Elmer). 15μl of the PCR mix after PCR amplification were loaded on an Agarose gel.  
 
Yeast methods 
 
Strains, growth and media 
 
The S. cerevisiae strain PJ69-4A (James et al., 1996) was used for all two hybrid 
experiments, the genotype of which is: 
MATα, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80 Δ, LYS2::GAL1UAS-
GAL1TATA-HIS3, GAL2UAS-GAL2TATA-ADE2, MEL1 met2=GAL7-LacZ. 
Yeasts were grown in either YPDA or SC dropout media selecting for appropriate 
plasmids at 30°C. Short term storage was on plates at 4°C. 
YPDA media consisted of 20g/l peptone (Difco/Becton-Dickinson), 10g/l yeast 
extract (Difco), and 20g/l glucose (plus 20g/l Bacto-agar for YPDA-agar). The media was 
then sterilized in an autoclave and, after cooling to approximately 55°C, 6ml 0.2% 
filtered adenine hemi sulfate was added. 
Synthetic complete (SC) dropout media was prepared as follows: 
Amino acid base (-His/-Trp/-Leu/-Ura) was prepared by mixing 20g alanine, arginine, 
asparagine, aspartic acid, cysteine, glutammine, glutammic acid, glycine, inositol, 
isoleucine, lysine, methionine, phenylalanine, proline, serine, threonine, tyrosine, and 
valine with 5g adenine and 2g para-aminobenzoic acid. To prepare dropout mixes, 36.7g 
of amino acid base was mixed with either 2g histidine, 4g leucine, 2g triptophane, or 2g 
uracile, as appropriate to form the appropriate dropout mix. SC dropout mix consisted of 
6.7g/l nitrogen base (without amino acid, Difco), 2g/l appropriate dropout mix, 20g/l 
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glucose and pH adjusted to between 5.5 and 6.5 (plus 20g/l Bacto-agar for SC dropout 
agar). After autoclaving and cooling to approximatively 55°C, 6ml 0.2% sterile filtered 
adenine hemisulfate was added, unless dropout media was also to be –adenine. 
 
Yeast transformation (frozen cell method)  
 
To prepare frozen competent yeast cells, several colonies were picked from a 
freshly grown plate and grown overnight in YPDA at 30°C with shaking. The following 
morning the overnight culture was diluted to an OD600 of 0.15 in fresh medium and 
grown at 30°C to an OD600 of 0.5-0.6 (1.2-1.5X107 cells). The cells were then harvested 
at 3000 rpm for 2 min at room temperature. The cells were then washed in one half 
culture volume sterile water and spun as before. An additional spin was made to remove 
residual supernatant. The cells were then resuspended in 1/8 culture volume of LiSorb 
(100mM LiOAc, 10mM Tris-HCl, pH 8.0, 1M sorbitol (molecular biology quality, filter 
sterilized). The resuspended pellet was incubated for 5 min at room temperature before 
being spun as before. An additional spin was made to remove residual supernatant. The 
cell pellet was again resuspended in LiSorb (600µl per 100ml original culture). Carrier 
DNA was then added (10µl per 100µl yeast of 10mg/ml salmon sperm DNA (Gibco), 
heat-treated at 95°C for 5 min.) Cells were then aliquoted and frozen directly in a -80°C 
freezer where they were stored until use. 
To transform frozen yeast cells, the cells were thawed at room temperature. 25µl 
cells were used per transformation. 0.5µl plasmid DNA for transformation was added to 
the cells, followed by 150µl LiPEG (100mM LiOAC, 10mM Tris-HCl, pH 8.0, 1mM 
EDTA, pH 8.0, 40% PEG3350, filter sterilize) The cells were then vortexed and 
incubated for 20 min. at room temperature. 17.5µl DMSO was then added and the cells 
were heat shocked for 15 min. in a 42°C water bath. The cells were then pelleted at low 
speed in a centrifuge, the supernatant removed, and the cells resuspended in 200µl sterile 
PBS. 100µl were plated onto appropriate selective plates and grown at 30°C. 
. 
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Biochemistry 
 
Western blotting 
 
Cell lysates were obtained by lysing the cells in cell lysis buffer plus a cocktail of 
proteases inhibitors. The lysates were then clarified by centrifugation at 13000 rpm at 
4°C. Cell lysates derived from different cell lines under different experimental conditions 
were resolved by SDS PAGE according to standard procedures. Gels were transferred to 
nitrocellulose membranes by semi-dry blotting for 1 hour at 1mA per membrane cm2. 
The membranes were then washed twice in PBS and incubated with blocking solution 
(PBS, 0.1% tween20, 4% milk powder) for1 hour at room temperature. 
Following the saturation with the blocking solution, membranes were incubated 
either for 2 hours at room temperature or for overnight at 4°C with primary antibody 
diluted in blocking solution. Subsequently, membranes were washed for 3 times 20 min. 
in PBS plus 0.1% tween20 at room temperature to remove the excess of the primary 
antibody. The secondary antibody linked to Horse Radish Peroxidase (HRP) was used to 
specifically recognize the primary antibody. After incubation with the secondary 
antibody for 1 hour at room temperature, membranes were washed again for 3 times 10 
min. in PBS plus 0.1% tween20. To visualize the HRP enzymatic activity, ECL solution 
(Amersham) was incubated on the membrane for 1 min. at room temperature and the 
membranes were then exposed to X-ray-film.  
 
Recombinant protein purification 
 
The purification of the recombinant protein used for the anti-Mig6 antibody 
production and the immunization of the rabbits were conducted in collaboration with 
Rodrigo Sanchez. 
For the purification of the Mig6 recombinant protein the expression plasmids 
pGEX-GST-Mig6 (kindly provided by Dr Axel Ullrich), containing the Mig6 C-terminal 
half cDNA (from a.a. 273 to 459), the pDest15-Mig6 full length, N-terminal and ΔCRIB 
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were transformed by the heat shock method into the BL21 E.Coli strain. A single BL21 
colony transformed with the expression plasmids were selected using the ampicillin 
resistance and inoculated into 500ml of LB broth media in the presence of ampicillin. 
The bacterial culture was grown at 37°C in constant agitation until the absorbance at 750 
nm reached the value of 0.4 (O.D.750: 0.4). The recombinant proteins were then induced 
adding 1mM isopropyl-D-1-thiogalactopyranoside (IPTG) for 2 hours at 37°C in constant 
agitation. The bacteria were pelleted at 4000 rpm in a 4°C centrifuge. The bacterial pellet 
was washed twice in cold PBS and resuspended in 50 ml of PBS containing a cocktail of 
protease inhibitors purchased by Roche diagnostics and 1mM of 1,4-DiThioThreitol 
(DTT). The bacteria were mechanically lysed by passing the bacterial suspention 4 times 
through a French press. The lysate was first clarified at 4°C by centrifugation at 10.000 
rpm for 10 min. and then by filtration using 0.24μm pore filter. The recombinant protein 
used for antibody production was then purified by Fast Protein Liquid Chromatography 
(FPLC) using the ÄKTA EXPLORER FPLC device. In brief a ready to use 1ml affinity 
chromatography column (Pharmacia GSTRAPTM FF 1ml) containing immobilized 
glutathione was equilibrated with 10 volume of PBS. The recombinant protein was 
purified by applying 1ml per minute of the clarified bacterial lysate to the affinity 
chromatography column that was then washed with 15ml of PBS. The recombinant 
protein was eluted with 10ml of TRIS buffer (50mM pH. 8) containing 10mM 
glutathione. The eluate was collected into 10 separate fractions of 1ml. The fractions 
containing the highest concentration of recombinant Mig6 protein were then dialyzed in 
PBS and concentrated to approximately 1mg/ml using CENTRIPLUS YM10 centrifugal 
filter device (Millipore Corporation) with an exclusion molecular weight of 30.000 
Dalton.  
 
Pull down 
 
The bacteria transformed with the different expression plasmid were lysed and 
clarified as described above. 10% glycerol was added and the lysate further centrifuged at 
13000 rpm for 15 min. at 4°C. The supernatant was recovered, aliquoted and stored at -
80°C. 25μl for each recombinant protein were incubated 1 hour at 4°C with 20μl of 
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glutathione-sepharose beads in a final volume of 500µl. The beads were washed several 
times with cell lysis buffer and incubated for 1 hour at 4°C with protein derived from cell 
in different experimental conditions. The supernatant was removed and the beads washed 
several times with the cell lysis buffer. SDS-PAGE loading buffer was added and the 
samples denatured by incubation at 95°C for 4 min. The samples were then loaded on a 
SDS-PAGE gel as described above.    
 
Immunization of the rabbit   
 
In order to raise the basal immunogenic response of the White New Zeeland 
Rabbits 1 ml of the Freunds adjuvant completed with mycobacterium tuberculosis was 
subcutaneously injected in the animals. After 14 days from this first injection, the rabbits 
were immunized  subcutaneously injecting 150μg of recombinant Mig6 protein 
resuspended into an equal volume of Freunds Adjuvant (without mycobacterium 
tuberculosis). All the following immunizations were performed in 14 days intervals. 
After the 6th immunization the rabbits were sacrificed and the blood harvested. The blood 
was incubated at 37°C for 1 hour and the cloth removed. The blood was then incubated 
overnight at 4°C and clarified by centrifugation at 12.000 rpm. Finally, the crude anti-
Mig6 anti-serum was harvested.   
 
Antigen purification of the antibody 
 
The anti-Mig6 antibody was antigen purified using Affigel beads (BIORAD). 2ml 
of Affigel beads were covalently coupled with 2mg of Mig6-GST antigen according to 
the manufacturer instruction. 12ml of the crude anti-Mig6 anti-serum was incubated 2h at 
4°C with the antigen pre-coupled Affigel beads. The Mig6 antibody was then eluted from 
the beads with 10 ml of Glycin (0.2M, pH 2.8). The eluate was collected in 10 separated 
fractions of 1 ml. In order to neutralize the acidic pH of the Glycin, 200µl of TRIS (1M, 
pH8) was then added to each of the fractions. The quality and the concentration of the 
purified antibody were controlled by loading 10µl of each fraction onto a SDS-PAGE gel 
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and a Comassie blue staining was performed. 3 fractions containing the highest 
concentration of the purified Mig6 antibody were mixed and stored at -80°C.  
  
Cell cultures  
 
MLP29 and C2C12 cell lines 
 
MLP29 and C2C12 cell line were grown in DMEM medium containing 10% Fetal 
Bovine Serum (FBS, GIBCO), 1% glutammine and 1% Penicilline/Streptomycine (P/S) 
at 37°C in the presence of 5% CO2. The cells were starved in DMEM + 0.1% FBS for 
different amounts of time depending on the experiment and stimulated for different 
length of time with 40ng/ml human recombinant HGF (R&D), 30ng/ml human 
recombinant PDGF (Sigma) or 25ng/ml of human recombinant FGF2 (Sigma). 
 
Cortical neuron culture and electroporation 
 
All the experiments with cortical neurons were performed in collaboration with 
Fabienne Lamballe and Flavio Maina.  
The day before the cortical neuron culture, Boyden chamber and coverslips were 
coated with poly-Ornithin (Poly-O) for 3 hours at room temperature. The poly-O solution 
was removed and the membrane or the coverslips dried at room temperature for 30 min. 
Boyden chamber and coverslips were then incubated with DMEM plus 10% horse serum 
(Gibco) in the cell incubator. 
The cortical neurons were taken from E15.5 embryos. Embryos were taken out 
from the uterus and kept on ice in HBSS buffer (Gibco). Brain cortices were cut off from 
the midbrain and brainstem and meninges were pulled off. The striatum was cut out. The 
cortices were incubated with Trypsin-EDTA (Gibco) at 37°C for 15 min. The Trypsin-
EDTA was removed and the cortices washed 3 times with DMEM plus 10% HS in order 
to neutralize the trypsin. Cells were then dissociated with a Pasteur glass pipette in 1.5ml 
of DMEM plus 10% Horse Serum (HS, Gibco). 
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For the electroporation 6X105 cells were mixed with 12μg of expression plasmid 
and cold PBS up to a final volume of 100μl. The mixture was transferred into 
electroporation cuvettes (MBP molecular bioproducts) and electroporated (5 pulses of 3 
msec separated by 1 sec interval at 270 V) with an electroporator device (Electrosqare 
porator ECM830, BTX). The cells were then incubated on ice for 10 min., resuspended 
and plated either onto the upper compartment of the Boyden chamber or onto coverslips. 
After 3 hours the media was changed into DMEM-F12 (Gibco) plus P/S plus 10% HS. 
The cells were then stimulated with the appropriate growth factors as described above 
and fixed after 18 hours. 
 
SCGs cultures 
 
All the experiments using SCGs were performed in collaboration with Jane 
Thompson and Alun Davies. 
Superior cervical ganglia were dissected from P40 CD1 mice. The ganglia were 
treated with 2mg/ml collagenase in HBSS for 30 min. at 4°C before trypsinization for 20 
min. at 37°C and trituration. Most of the non neuronal cells were removed by differential 
sedimentation and the neurons (>90% pure) were plated in defined, serum-free medium 
in 35-mm culture dishes coated with poly-O and Laminin. The neurons were then 
stimulated with HGF. 
To study survival under different experimental conditions, neurons were plated at 
low density (100 to 300 neurons per 35-mm dish), and the number of neurons attached 
within a 12X12 mm grid in the center of each dish was counted 6 hours after plating. The 
number of neurons surviving in this grid was then counted at 24 hourly intervals, and the 
number of surviving neurons in the grid at these time points was expressed as a 
percentage of the initial count taken at 6 hours. In each experiment, triplicate cultures 
were set up for all conditions. 
To study neurite out-growth, cultures were set up following the same 
experimental procedures as before, except that the neurons were plated at higher density 
(400 to 800 neurons per 35-mm dish). Total neurite length was measured for each 
experimental condition using digital stereology (Kinetic imaging Ltd.), and the average 
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neurite length per neuron was calculated dividing this figure by neuron number per unit 
area. 
For protein extraction, primary culture of dissociated P20 SCGs neurons were 
grown for 3 to 6 hours in culture before being stimulated for different time with HGF. 
Cells were harvested and homogenized as described above. 
 
Trophoblast Stem (TS) cells culture 
 
TS cells were generously provided by Janet Rossant laboratory (Tanaka et al., 
1998, science). The Feeder Conditioned Medium (Feeder-CM) was used to culture the TS 
cells in the absence of fibroblasts. In order to prepare the Feeder-CM medium, primary 
Embryonic Fibrolasts (EMFIs) were prepared from E13.5 CD1 embryos. 2X106 cells 
were plated into 10cm dish in RPMI medium (Gibco). The EMFIs were treated with 
MitomycinC for 2 hours and washed extensively with RPMI medium. 10ml of RPMI 
medium were added to the cells and after 72 hours the media was collected and clarified 
by centrifugation at 1000 rpm 15 min. TS cells were grown on 10cm dishes in RPMI 
(Gibco) plus P/S plus 70% of Feeder-CM plus 25ng/ml of FGF4 (Sigma) and 1μg/ml of 
heparin (Sigma). 
 
Plasmid transfection and Boyden chamber assay 
 
All the migration assays were repeated with independent sets of cells at least 
twice and each experimental condition was carried out at least in duplicate. The numbers 
of Hoechst positive nuclei were counted in six visual fields for each experimental 
condition. 
MLP29 cells were grown in DMEM media supplemented with 10% FBS (Gibco), 
glutammine (Q, Gibco) and 1% of a mixture of penicilline/streptomycine at 37°C in the 
presence of 5% CO2. One day before transfection the cells were trypsinized and 106 cells 
were seeded on a 10cm dish (Falkon). The day of transfection the media was changed and 
5ml of DMEM supplemented with Q and P/S (without FBS) were added to the media. 
10μg expression plasmids were mixed with 1μg of Yellow Fluorescent Protein (YFP) 
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plasmid, Optimem serum-free medium (Invitrogen) and 24μl of Lipofectamine2000 
reagent (Invitrogen) following the manufacturer instructions. The mixture was incubated 
for 20 min. at room temperature and then gently dropped onto the cells. The cells were 
then returned to the incubator for 4 hours. 5ml of DMEM supplemented with 20% FBS, 
Q and P/S were added to the cells for another 18 hours.  
For the migration assay experiments, the membranes of the Boyden chamber 
(8µm pore size, Costar) were coated for 18 hours at 4°C with 0.15μg per cm2 of 
fibronectin (Sigma). The filters were then washed twice with PBS and incubated for 1-2 
hours with DMEM plus 0.1% FBS in the cell incubator. After transfection, the cells were 
starved in DMEM plus 0.1% FBS plus Q and P/S for 24 hours, harvested and 105 cells 
were seeded either in the upper compartment of the Boyden chamber or on coverslips for 
immunofluorescense analysis. The Boyden chamber was then transferred to the cell 
incubator for an additional 3 hours and either DMEM plus 10% FBS or 40ng/ml of 
human recombinant HGF was added for 18 hours to the lower compartment. The 
membranes were washed once with PBS and the cell fixed at room temperature for 15 
min. with 4% paraformaldheyde (PFA). The filters were then washed twice with PBS, the 
upper compartment cells were scraped off the membrane and the nuclei stained with 
Hoechst fluorescent dye. The filters were directly analyzed under a Zeiss fluorescent 
microscope. 
 
SiRNA transfection and Boyden chamber assay 
 
5μl stock solution (400μM) of the sense and anti-sense siRNA oligonucleotides 
(DARMAKOM) were mixed with 90μl of annealing buffer. The siRNAs were denatured 
for 1 min at 90°C and annealed by 1 hour incubation at 37°C. The annealed solution of 
siRNA duplex was aliquoted and stored at -20°C. 
MLP29 cells (4X105) were plated on 10cm dishes (Falkon) the day before 
transfection. After few hours the media was changed into DMEM plus 0.1% FBS. For 
every 10 cm dish, 5μl of either Mig6 or GFP siRNA duplex were mixed with Optimem 
and with 9μl of Oligofectamine (Invitrogen) according to the manufacturer instructions. 
The solution was then incubated at room temperature for 20 min. and gently pipetted onto 
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the cells. After 96 hours the cells were transfected a second time as above and 
Aphidicolin was eventually added at this step. After another 24 hours the cell were either 
lysed for western blotting analysis or harvested, and seeded either onto coverslips for 
BrdU incorporation assay and immunofluorescence analysis or onto the upper 
compartment of the Boyden chamber in the presence or the absence of Aphidicolin and 
the migration assay was performed as described above.  
 
BrdU assay 
 
After the transfection with either siRNA or with overexpression plasmids, the 
cells were stimulated as described above. 100μM of Bromodeoxyuridine (BrdU) was 
added to the culture media for the last 2 hours of stimulation. MLP29 cells were then 
fixed in Methanol and the BrdU was visualized by immunofluorescence analysis. The 
percent of BrdU positive versus Hoechst positive nuclei was calculated.  
 
Immunofluorescence 
 
After transfection of either siRNA oligos or overexpressing constructs as 
described before the cells were fixed 15 min. at room temperature with 4% PFA and 4% 
sucrose. In order to deactivate the PFA, the cells were incubated for 10 min. at room 
temperature with 50mM NH4Cl. The cells were then permeabilized by incubation for 5 
min. at room temperature with PBS plus 0.1% tritonX100, washed 3 times in PBS and 
incubated for 1 hour at room temperature with blocking solution (PBS, 5% sheep serum, 
5% goat serum). The cells were incubated for 2 hours at room temperature with the 
primary antibody diluted in blocking solution. The excess of the primary antibody was 
removed by washing at room temperature 3 times with PBS and the cells were incubated 
for 30 min. at room temperature with the fluorophore-conjugated secondary antibody. 
Finally the cells were washed 3 times at room temperature with PBS and the coverslips 
mounted with an aqueous solution mounting medium (MOWIOL). 
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Mouse work 
 
Mutant and control mice were maintained in a mixed genetic background 
(C57/Black6/CD1). For experiments with adult mice, mice were separated from their 
parents at the age of around 3 weeks and males and females were housed separately. Tail 
biopsies were taken and mice were ear tagged using six-digit ear tags from Natialband & 
tag company. For the experiments with embryos, breedings were set up with one male 
and two females. Vaginal plug-checks were done starting the following morning. A plug 
was counted as pregnancy for 0.5 days. Embryos were taken according to experimental 
procedures. For genotyping of embryos younger than E13.5 yolk sacs were separated 
from the placenta and used for subsequent DNA extraction. 
 
Histology 
 
Cryostat sections and in-situ hybridization 
 
Cryostat sections of E13.5 embryos were used for in-situ hybridization. Embryos 
were dissected in PBS and fixed overnight in 4% PFA at 4°C. They were washed 3 times 
in cold PBS and placed in a 30% sucrose solution for overnight at 4°C. OCT embedding 
medium was placed in embedding molds and embryos were dried and placed into the 
embedding medium. Subsequently, the embedding molds were placed in isopentane that 
was in turn submerged in liquid nitrogen for several minutes in order to harden the 
embedding medium. For sections on the slides, 18μm serial sections were cut at -20°C 
and directly transferred to gelatin coated slides (Menzel-gläser). The sections were either 
processed directly or stored at -20°C for later processing. The sections were incubated 
overnight at 70°C with 200μl of hybridization buffer plus 80μl of labeled probe. The 
excess of probe was washed away at 65°C 3 times with washing buffer. The tissue was 
then blocked for 1 hour at room temperature with 1ml of blocking solution containing 2% 
blocking agent (Roche), 20% sheep serum and 0.1% tween20. The labeled probe was 
then recognized by an anti-digoxigenin specific antibody (Roche) conjugated with the 
alkaline phosphatase (ROCHE). Thus the tissue was incubated for overnight with the 
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anti-digoxigenin specific antibody diluted 1:2000 in blocking solution. Excess antibody 
was removed by washing the slides several times in MABT at room temperature. The 
alkaline phosphatase enzymatic activity was then visualized incubating the slides for 
several hours with a mixture of substrate colorants (NBT and BCIP). Subsequently, the 
slides were washed in PBS plus 0.1% tween20 and fixed overnight with 4% PFA.  
 
Whole mount in-situ hybridization 
 
E9.5 wild type and mutant embryos were dissected in PBS and dehydrated by 
solutions containing increasing concentrations of methanol. The embryos were stored at -
20°C in 100% methanol for several weeks. In order to inhibit endogenous alkaline 
phosphatases the embryos were washed in a solution containing 80% methanol plus 6% 
H2O2 for 1 hour at room temperature. The embryos were then rehydrated by incubation in 
a reverse methanol series, washed 3 times for 5 min. with PBS plus 0.1% tween20 and 
digested in a 20mg/ml of proteinaseK solution for 30 min. at room temperature. The 
embryos were then post-fixed in a solution containing 4% PFA and 0.2% glutaraldheyde 
at 4°C. The embryos were then blocked for 1h at 70°C in prehybridization solution. 40µl 
of labeled probe was added to 1ml of prehybridization solution and the embryos 
incubated at 70°C for 18 hours. Excess probe was removed by 3 washes of 30 min. each 
in 3 different washing solutions with increasing stringency properties: wash I at 70°C 
(50% formamide, 5X SSC pH4.5, 0.1% tween20, 0.5% chaps), wash II at 65°C (50% 
formamide, 2X SSC pH4.5, 0.1% tween20, 0.5% chaps), wash III at 65°C (2X SSC 
pH4.5, 0.1% tween20, 0.5% chaps). Meanwhile 2µl/ml of the anti-digoxigenin specific 
antibody was preabsorbed in a solution containing 8mg of embryo powder for 2 hours at 
4°C. The embryo powder was removed by centrifugation and the supernatant mixed with 
a solution containing 2% blocking reagent and 20% sheep serum. The embryos were then 
incubated with the antibody solution for 18 hours at 4°C. Excess of the antibody was 
removed by several washes in PBS plus 0.1% tween20 and the antibody detected as 
described before.   
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Cryosections of gelatin embedded whole mount in-situ hybridization 
 
The whole mount in-situ hybridizations were fixed in 4% PFA for overnight at 
4°C, washed 3 times for 5 min in PBS and incubated in a solution of PBS plus 20% 
sucrose for 3 hours. The embryos were then transferred into embedding molds containing 
the embedding gelatin solution (7.5% gelatin, 50% sucrose) and left on ice for several 
minutes. When the gelatin solution was hardened and the embedding molds were frozen 
in dry ice and 25μm sections were then cut at -20°C using the cryostat.  
 
Antibody staining on cryostat sections 
 
18μm cryostat sagittal sections of E15.5 embryos were cut as described above. 
The sections were dried at 37°C for 30 min. and washed in PBS for 5 min. The sections 
were fixed with 4% PFA for 5 min. at room temperature and washed once with PBS. The 
tissue was permeabilized washing the sections 3 times with PBS plus 0.5% tritonX100 
for 15 min. The sections were then washed 2 times in PBS and incubated for 1 hour at 
room temperature with blocking solution (0.5% tritonX100, 5% sheep serum, 5% goat 
serum). In order to verify the antibody specificity, the primary anti-Mig6 specific 
antibody was then diluted 1:100 in blocking solution and incubated with either 5μg/ml of 
GST or 5µg /ml of GST-Mig6 antigen fusion protein for 3 hours at 4°C. The primary 
antibody was then incubated on the sections for 2 hours at room temperature. Excess 
antibody was removed by washing 3 times in PBS plus 0.5% tritonX100. The sections 
were blocked again for 1 hour at room temperature with blocking solution and incubated 
with the fluorophore-conjugated secondary antibody. Excess secondary antibody was 
removed by washing 3 times with PBS plus 0.5% tritonX100 and the slides were 
mounted with an aqueous mounting media (MOWIOL). The sections were directly 
analyzed with a fluorescent microscope and representative pictures taken.    
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